Found 53 hits Enz. Inhib. hit(s) with all data for entry = 50001353 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277053
(CHEMBL4174382)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H220N44O48S2/c1-70(2)50-94(131(225)174-93(45-49-244-9)130(224)181-100(57-112(156)207)140(234)193-118(73(6)199)121(157)215)176-134(228)99(55-80-61-165-86-27-17-16-26-84(80)86)180-129(223)92(41-44-111(155)206)175-146(240)117(71(3)4)192-138(232)97(51-76-22-12-10-13-23-76)179-135(229)101(58-114(209)210)182-128(222)91(40-43-110(154)205)169-122(216)72(5)168-125(219)88(29-20-47-163-149(158)159)170-126(220)89(30-21-48-164-150(160)161)172-143(237)106(66-197)188-137(231)103(60-116(213)214)184-145(239)108(68-243)190-133(227)96(54-79-33-37-83(203)38-34-79)177-127(221)87(28-18-19-46-151)171-142(236)105(65-196)187-132(226)95(53-78-31-35-82(202)36-32-78)178-136(230)102(59-115(211)212)183-144(238)107(67-198)189-148(242)120(75(8)201)194-139(233)98(52-77-24-14-11-15-25-77)185-147(241)119(74(7)200)191-113(208)63-166-124(218)90(39-42-109(153)204)173-141(235)104(64-195)186-123(217)85(152)56-81-62-162-69-167-81/h10-17,22-27,31-38,61-62,69-75,85,87-108,117-120,165,195-203,243H,18-21,28-30,39-60,63-68,151-152H2,1-9H3,(H2,153,204)(H2,154,205)(H2,155,206)(H2,156,207)(H2,157,215)(H,162,167)(H,166,218)(H,168,219)(H,169,216)(H,170,220)(H,171,236)(H,172,237)(H,173,235)(H,174,225)(H,175,240)(H,176,228)(H,177,221)(H,178,230)(H,179,229)(H,180,223)(H,181,224)(H,182,222)(H,183,238)(H,184,239)(H,185,241)(H,186,217)(H,187,226)(H,188,231)(H,189,242)(H,190,227)(H,191,208)(H,192,232)(H,193,234)(H,194,233)(H,209,210)(H,211,212)(H,213,214)(H4,158,159,163)(H4,160,161,164)/t72-,73+,74+,75+,85-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277058
(CHEMBL4165144)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CSC1CC(=O)N(CCCCCCCCCCCC(O)=O)C1=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C169H251N45O52S2/c1-84(2)62-108(148(247)192-107(56-61-267-10)147(246)200-115(70-128(175)227)158(257)212-136(87(7)219)139(176)238)195-152(251)114(68-94-75-184-100-37-26-25-36-98(94)100)199-146(245)106(52-55-127(174)226)193-164(263)135(86(5)6)211-156(255)112(64-90-32-20-18-21-33-90)198-153(252)116(71-132(232)233)201-145(244)105(51-54-126(173)225)191-163(262)123(82-268-124-74-130(229)214(167(124)266)60-29-17-15-13-11-12-14-16-24-41-131(230)231)209-144(243)103(40-31-59-183-169(179)180)187-142(241)102(39-30-58-182-168(177)178)189-161(260)121(80-217)207-155(254)118(73-134(236)237)202-149(248)109(63-85(3)4)194-150(249)110(66-92-42-46-96(222)47-43-92)196-143(242)101(38-27-28-57-170)188-160(259)120(79-216)206-151(250)111(67-93-44-48-97(223)49-45-93)197-154(253)117(72-133(234)235)203-162(261)122(81-218)208-166(265)138(89(9)221)213-157(256)113(65-91-34-22-19-23-35-91)204-165(264)137(88(8)220)210-129(228)77-185-141(240)104(50-53-125(172)224)190-159(258)119(78-215)205-140(239)99(171)69-95-76-181-83-186-95/h18-23,25-26,32-37,42-49,75-76,83-89,99,101-124,135-138,184,215-223H,11-17,24,27-31,38-41,50-74,77-82,170-171H2,1-10H3,(H2,172,224)(H2,173,225)(H2,174,226)(H2,175,227)(H2,176,238)(H,181,186)(H,185,240)(H,187,241)(H,188,259)(H,189,260)(H,190,258)(H,191,262)(H,192,247)(H,193,263)(H,194,249)(H,195,251)(H,196,242)(H,197,253)(H,198,252)(H,199,245)(H,200,246)(H,201,244)(H,202,248)(H,203,261)(H,204,264)(H,205,239)(H,206,250)(H,207,254)(H,208,265)(H,209,243)(H,210,228)(H,211,255)(H,212,257)(H,213,256)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H4,177,178,182)(H4,179,180,183)/t87-,88-,89-,99+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124?,135+,136+,137+,138+/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277055
(CHEMBL4169653)Show SMILES CCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C169H253N45O49S2/c1-13-14-15-16-17-18-19-20-21-32-62-214-131(228)76-125(167(214)263)265-83-124(163(259)191-105(43-34-61-183-169(179)180)144(240)189-104(42-33-60-182-168(177)178)143(239)187-88(8)140(236)188-107(53-56-127(173)224)146(242)202-118(73-132(229)230)154(250)199-114(66-92-35-24-22-25-36-92)157(253)211-135(87(6)7)164(260)194-108(54-57-128(174)225)147(243)200-116(70-96-77-184-102-40-29-28-39-100(96)102)153(249)196-110(64-85(2)3)149(245)193-109(58-63-264-12)148(244)201-117(72-129(175)226)159(255)212-136(89(9)218)139(176)235)209-156(252)120(75-134(233)234)203-150(246)111(65-86(4)5)195-151(247)112(68-94-44-48-98(221)49-45-94)197-145(241)103(41-30-31-59-170)190-161(257)122(81-216)207-152(248)113(69-95-46-50-99(222)51-47-95)198-155(251)119(74-133(231)232)204-162(258)123(82-217)208-166(262)138(91(11)220)213-158(254)115(67-93-37-26-23-27-38-93)205-165(261)137(90(10)219)210-130(227)79-185-142(238)106(52-55-126(172)223)192-160(256)121(80-215)206-141(237)101(171)71-97-78-181-84-186-97/h22-29,35-40,44-51,77-78,84-91,101,103-125,135-138,184,215-222H,13-21,30-34,41-43,52-76,79-83,170-171H2,1-12H3,(H2,172,223)(H2,173,224)(H2,174,225)(H2,175,226)(H2,176,235)(H,181,186)(H,185,238)(H,187,239)(H,188,236)(H,189,240)(H,190,257)(H,191,259)(H,192,256)(H,193,245)(H,194,260)(H,195,247)(H,196,249)(H,197,241)(H,198,251)(H,199,250)(H,200,243)(H,201,244)(H,202,242)(H,203,246)(H,204,258)(H,205,261)(H,206,237)(H,207,248)(H,208,262)(H,209,252)(H,210,227)(H,211,253)(H,212,255)(H,213,254)(H,229,230)(H,231,232)(H,233,234)(H4,177,178,182)(H4,179,180,183)/t88-,89+,90+,91+,101-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125?,135-,136-,137-,138-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277056
(CHEMBL4163714)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C152H226N44O46S2/c1-72(2)52-97(133(225)176-96(47-51-244-11)132(224)184-104(60-115(158)209)142(234)195-120(76(8)201)123(159)215)179-137(229)103(58-83-63-167-89-29-19-18-28-87(83)89)183-131(223)95(43-46-114(157)208)177-148(240)119(74(5)6)194-140(232)101(54-79-24-14-12-15-25-79)182-138(230)105(61-117(211)212)185-130(222)94(42-45-113(156)207)171-124(216)75(7)170-127(219)91(31-22-49-165-151(160)161)172-128(220)92(32-23-50-166-152(162)163)174-145(237)109(68-199)190-147(239)111(70-243)192-134(226)98(53-73(3)4)178-135(227)99(56-81-33-37-85(204)38-34-81)180-129(221)90(30-20-21-48-153)173-144(236)108(67-198)189-136(228)100(57-82-35-39-86(205)40-36-82)181-139(231)106(62-118(213)214)186-146(238)110(69-200)191-150(242)122(78(10)203)196-141(233)102(55-80-26-16-13-17-27-80)187-149(241)121(77(9)202)193-116(210)65-168-126(218)93(41-44-112(155)206)175-143(235)107(66-197)188-125(217)88(154)59-84-64-164-71-169-84/h12-19,24-29,33-40,63-64,71-78,88,90-111,119-122,167,197-205,243H,20-23,30-32,41-62,65-70,153-154H2,1-11H3,(H2,155,206)(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,215)(H,164,169)(H,168,218)(H,170,219)(H,171,216)(H,172,220)(H,173,236)(H,174,237)(H,175,235)(H,176,225)(H,177,240)(H,178,227)(H,179,229)(H,180,221)(H,181,231)(H,182,230)(H,183,223)(H,184,224)(H,185,222)(H,186,238)(H,187,241)(H,188,217)(H,189,228)(H,190,239)(H,191,242)(H,192,226)(H,193,210)(H,194,232)(H,195,234)(H,196,233)(H,211,212)(H,213,214)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,119-,120-,121-,122-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.460 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277057
(CHEMBL4174154)Show SMILES CCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C163H241N45O49S2/c1-13-14-15-26-56-208-125(222)70-119(161(208)257)259-77-118(157(253)185-99(37-28-55-177-163(173)174)138(234)183-98(36-27-54-176-162(171)172)137(233)181-82(8)134(230)182-101(47-50-121(167)218)140(236)196-112(67-126(223)224)148(244)193-108(60-86-29-18-16-19-30-86)151(247)205-129(81(6)7)158(254)188-102(48-51-122(168)219)141(237)194-110(64-90-71-178-96-34-23-22-33-94(90)96)147(243)190-104(58-79(2)3)143(239)187-103(52-57-258-12)142(238)195-111(66-123(169)220)153(249)206-130(83(9)212)133(170)229)203-150(246)114(69-128(227)228)197-144(240)105(59-80(4)5)189-145(241)106(62-88-38-42-92(215)43-39-88)191-139(235)97(35-24-25-53-164)184-155(251)116(75-210)201-146(242)107(63-89-40-44-93(216)45-41-89)192-149(245)113(68-127(225)226)198-156(252)117(76-211)202-160(256)132(85(11)214)207-152(248)109(61-87-31-20-17-21-32-87)199-159(255)131(84(10)213)204-124(221)73-179-136(232)100(46-49-120(166)217)186-154(250)115(74-209)200-135(231)95(165)65-91-72-175-78-180-91/h16-23,29-34,38-45,71-72,78-85,95,97-119,129-132,178,209-216H,13-15,24-28,35-37,46-70,73-77,164-165H2,1-12H3,(H2,166,217)(H2,167,218)(H2,168,219)(H2,169,220)(H2,170,229)(H,175,180)(H,179,232)(H,181,233)(H,182,230)(H,183,234)(H,184,251)(H,185,253)(H,186,250)(H,187,239)(H,188,254)(H,189,241)(H,190,243)(H,191,235)(H,192,245)(H,193,244)(H,194,237)(H,195,238)(H,196,236)(H,197,240)(H,198,252)(H,199,255)(H,200,231)(H,201,242)(H,202,256)(H,203,246)(H,204,221)(H,205,247)(H,206,249)(H,207,248)(H,223,224)(H,225,226)(H,227,228)(H4,171,172,176)(H4,173,174,177)/t82-,83+,84+,85+,95-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119?,129-,130-,131-,132-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.860 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277058
(CHEMBL4165144)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CSC1CC(=O)N(CCCCCCCCCCCC(O)=O)C1=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C169H251N45O52S2/c1-84(2)62-108(148(247)192-107(56-61-267-10)147(246)200-115(70-128(175)227)158(257)212-136(87(7)219)139(176)238)195-152(251)114(68-94-75-184-100-37-26-25-36-98(94)100)199-146(245)106(52-55-127(174)226)193-164(263)135(86(5)6)211-156(255)112(64-90-32-20-18-21-33-90)198-153(252)116(71-132(232)233)201-145(244)105(51-54-126(173)225)191-163(262)123(82-268-124-74-130(229)214(167(124)266)60-29-17-15-13-11-12-14-16-24-41-131(230)231)209-144(243)103(40-31-59-183-169(179)180)187-142(241)102(39-30-58-182-168(177)178)189-161(260)121(80-217)207-155(254)118(73-134(236)237)202-149(248)109(63-85(3)4)194-150(249)110(66-92-42-46-96(222)47-43-92)196-143(242)101(38-27-28-57-170)188-160(259)120(79-216)206-151(250)111(67-93-44-48-97(223)49-45-93)197-154(253)117(72-133(234)235)203-162(261)122(81-218)208-166(265)138(89(9)221)213-157(256)113(65-91-34-22-19-23-35-91)204-165(264)137(88(8)220)210-129(228)77-185-141(240)104(50-53-125(172)224)190-159(258)119(78-215)205-140(239)99(171)69-95-76-181-83-186-95/h18-23,25-26,32-37,42-49,75-76,83-89,99,101-124,135-138,184,215-223H,11-17,24,27-31,38-41,50-74,77-82,170-171H2,1-10H3,(H2,172,224)(H2,173,225)(H2,174,226)(H2,175,227)(H2,176,238)(H,181,186)(H,185,240)(H,187,241)(H,188,259)(H,189,260)(H,190,258)(H,191,262)(H,192,247)(H,193,263)(H,194,249)(H,195,251)(H,196,242)(H,197,253)(H,198,252)(H,199,245)(H,200,246)(H,201,244)(H,202,248)(H,203,261)(H,204,264)(H,205,239)(H,206,250)(H,207,254)(H,208,265)(H,209,243)(H,210,228)(H,211,255)(H,212,257)(H,213,256)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H4,177,178,182)(H4,179,180,183)/t87-,88-,89-,99+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124?,135+,136+,137+,138+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277059
(CHEMBL4177064)Show SMILES CCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C166H246N42O50S2/c1-13-14-15-16-17-18-19-20-21-32-59-208-129(223)73-123(165(208)258)260-81-122(161(254)184-102(41-33-58-177-166(174)175)141(234)181-86(8)138(231)182-104(51-54-125(170)219)143(236)195-115(70-130(224)225)151(244)192-111(63-90-34-24-22-25-35-90)154(247)205-133(85(6)7)162(255)187-105(52-55-126(171)220)144(237)193-113(67-94-74-178-100-39-29-28-38-98(94)100)150(243)189-107(61-83(2)3)146(239)186-106(56-60-259-12)145(238)194-114(69-127(172)221)156(249)206-134(87(9)213)137(173)230)203-160(253)120(79-211)201-153(246)117(72-132(228)229)196-147(240)108(62-84(4)5)188-148(241)109(65-92-42-46-96(216)47-43-92)190-142(235)101(40-30-31-57-167)183-158(251)119(78-210)200-149(242)110(66-93-44-48-97(217)49-45-93)191-152(245)116(71-131(226)227)197-159(252)121(80-212)202-164(257)136(89(11)215)207-155(248)112(64-91-36-26-23-27-37-91)198-163(256)135(88(10)214)204-128(222)76-179-140(233)103(50-53-124(169)218)185-157(250)118(77-209)199-139(232)99(168)68-95-75-176-82-180-95/h22-29,34-39,42-49,74-75,82-89,99,101-123,133-136,178,209-217H,13-21,30-33,40-41,50-73,76-81,167-168H2,1-12H3,(H2,169,218)(H2,170,219)(H2,171,220)(H2,172,221)(H2,173,230)(H,176,180)(H,179,233)(H,181,234)(H,182,231)(H,183,251)(H,184,254)(H,185,250)(H,186,239)(H,187,255)(H,188,241)(H,189,243)(H,190,235)(H,191,245)(H,192,244)(H,193,237)(H,194,238)(H,195,236)(H,196,240)(H,197,252)(H,198,256)(H,199,232)(H,200,242)(H,201,246)(H,202,257)(H,203,253)(H,204,222)(H,205,247)(H,206,249)(H,207,248)(H,224,225)(H,226,227)(H,228,229)(H4,174,175,177)/t86-,87+,88+,89+,99-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123?,133-,134-,135-,136-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277055
(CHEMBL4169653)Show SMILES CCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C169H253N45O49S2/c1-13-14-15-16-17-18-19-20-21-32-62-214-131(228)76-125(167(214)263)265-83-124(163(259)191-105(43-34-61-183-169(179)180)144(240)189-104(42-33-60-182-168(177)178)143(239)187-88(8)140(236)188-107(53-56-127(173)224)146(242)202-118(73-132(229)230)154(250)199-114(66-92-35-24-22-25-36-92)157(253)211-135(87(6)7)164(260)194-108(54-57-128(174)225)147(243)200-116(70-96-77-184-102-40-29-28-39-100(96)102)153(249)196-110(64-85(2)3)149(245)193-109(58-63-264-12)148(244)201-117(72-129(175)226)159(255)212-136(89(9)218)139(176)235)209-156(252)120(75-134(233)234)203-150(246)111(65-86(4)5)195-151(247)112(68-94-44-48-98(221)49-45-94)197-145(241)103(41-30-31-59-170)190-161(257)122(81-216)207-152(248)113(69-95-46-50-99(222)51-47-95)198-155(251)119(74-133(231)232)204-162(258)123(82-217)208-166(262)138(91(11)220)213-158(254)115(67-93-37-26-23-27-38-93)205-165(261)137(90(10)219)210-130(227)79-185-142(238)106(52-55-126(172)223)192-160(256)121(80-215)206-141(237)101(171)71-97-78-181-84-186-97/h22-29,35-40,44-51,77-78,84-91,101,103-125,135-138,184,215-222H,13-21,30-34,41-43,52-76,79-83,170-171H2,1-12H3,(H2,172,223)(H2,173,224)(H2,174,225)(H2,175,226)(H2,176,235)(H,181,186)(H,185,238)(H,187,239)(H,188,236)(H,189,240)(H,190,257)(H,191,259)(H,192,256)(H,193,245)(H,194,260)(H,195,247)(H,196,249)(H,197,241)(H,198,251)(H,199,250)(H,200,243)(H,201,244)(H,202,242)(H,203,246)(H,204,258)(H,205,261)(H,206,237)(H,207,248)(H,208,262)(H,209,252)(H,210,227)(H,211,253)(H,212,255)(H,213,254)(H,229,230)(H,231,232)(H,233,234)(H4,177,178,182)(H4,179,180,183)/t88-,89+,90+,91+,101-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125?,135-,136-,137-,138-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277060
(CHEMBL4167331)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C152H226N44O46S2/c1-72(2)52-97(133(225)176-96(47-51-244-11)132(224)184-104(60-115(158)209)142(234)195-120(76(8)201)123(159)215)179-137(229)103(58-83-63-167-89-29-19-18-28-87(83)89)183-130(222)95(43-46-114(157)208)177-148(240)119(74(5)6)194-140(232)101(54-79-24-14-12-15-25-79)182-147(239)111(70-243)192-131(223)94(42-45-113(156)207)171-124(216)75(7)170-127(219)91(31-22-49-165-151(160)161)172-128(220)92(32-23-50-166-152(162)163)174-145(237)109(68-199)190-139(231)106(62-118(213)214)185-134(226)98(53-73(3)4)178-135(227)99(56-81-33-37-85(204)38-34-81)180-129(221)90(30-20-21-48-153)173-144(236)108(67-198)189-136(228)100(57-82-35-39-86(205)40-36-82)181-138(230)105(61-117(211)212)186-146(238)110(69-200)191-150(242)122(78(10)203)196-141(233)102(55-80-26-16-13-17-27-80)187-149(241)121(77(9)202)193-116(210)65-168-126(218)93(41-44-112(155)206)175-143(235)107(66-197)188-125(217)88(154)59-84-64-164-71-169-84/h12-19,24-29,33-40,63-64,71-78,88,90-111,119-122,167,197-205,243H,20-23,30-32,41-62,65-70,153-154H2,1-11H3,(H2,155,206)(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,215)(H,164,169)(H,168,218)(H,170,219)(H,171,216)(H,172,220)(H,173,236)(H,174,237)(H,175,235)(H,176,225)(H,177,240)(H,178,227)(H,179,229)(H,180,221)(H,181,230)(H,182,239)(H,183,222)(H,184,224)(H,185,226)(H,186,238)(H,187,241)(H,188,217)(H,189,228)(H,190,231)(H,191,242)(H,192,223)(H,193,210)(H,194,232)(H,195,234)(H,196,233)(H,211,212)(H,213,214)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,119-,120-,121-,122-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277061
(CHEMBL4159256)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C153H226N44O47S2/c1-72(2)52-97(134(227)177-96(47-51-246-11)133(226)185-104(60-115(159)209)144(237)196-121(76(8)201)124(160)217)180-138(231)103(58-83-64-168-89-29-19-18-28-87(83)89)184-132(225)95(43-46-114(158)208)178-149(242)120(74(5)6)195-142(235)101(54-79-24-14-12-15-25-79)183-139(232)105(61-117(211)212)186-131(224)94(42-45-113(157)207)172-125(218)75(7)171-128(221)91(31-22-49-166-152(161)162)173-129(222)92(32-23-50-167-153(163)164)175-148(241)111(70-245)193-141(234)107(63-119(215)216)187-135(228)98(53-73(3)4)179-136(229)99(56-81-33-37-85(204)38-34-81)181-130(223)90(30-20-21-48-154)174-146(239)109(68-199)191-137(230)100(57-82-35-39-86(205)40-36-82)182-140(233)106(62-118(213)214)188-147(240)110(69-200)192-151(244)123(78(10)203)197-143(236)102(55-80-26-16-13-17-27-80)189-150(243)122(77(9)202)194-116(210)66-169-127(220)93(41-44-112(156)206)176-145(238)108(67-198)190-126(219)88(155)59-84-65-165-71-170-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,168,198-205,245H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H2,160,217)(H,165,170)(H,169,220)(H,171,221)(H,172,218)(H,173,222)(H,174,239)(H,175,241)(H,176,238)(H,177,227)(H,178,242)(H,179,229)(H,180,231)(H,181,223)(H,182,233)(H,183,232)(H,184,225)(H,185,226)(H,186,224)(H,187,228)(H,188,240)(H,189,243)(H,190,219)(H,191,230)(H,192,244)(H,193,234)(H,194,210)(H,195,235)(H,196,237)(H,197,236)(H,211,212)(H,213,214)(H,215,216)(H4,161,162,166)(H4,163,164,167)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.940 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277062
(CHEMBL4175452)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C153H226N44O48S/c1-72(2)52-97(134(228)177-96(47-51-246-11)133(227)185-104(60-115(159)210)144(238)196-121(76(8)202)124(160)218)180-138(232)103(58-83-64-168-89-29-19-18-28-87(83)89)184-132(226)95(43-46-114(158)209)178-149(243)120(74(5)6)195-142(236)101(54-79-24-14-12-15-25-79)183-139(233)105(61-117(212)213)186-131(225)94(42-45-113(157)208)172-125(219)75(7)171-128(222)91(31-22-49-166-152(161)162)173-129(223)92(32-23-50-167-153(163)164)175-147(241)110(69-200)192-141(235)107(63-119(216)217)187-135(229)98(53-73(3)4)179-136(230)99(56-81-33-37-85(205)38-34-81)181-130(224)90(30-20-21-48-154)174-146(240)109(68-199)191-137(231)100(57-82-35-39-86(206)40-36-82)182-140(234)106(62-118(214)215)188-148(242)111(70-201)193-151(245)123(78(10)204)197-143(237)102(55-80-26-16-13-17-27-80)189-150(244)122(77(9)203)194-116(211)66-169-127(221)93(41-44-112(156)207)176-145(239)108(67-198)190-126(220)88(155)59-84-65-165-71-170-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,168,198-206H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,210)(H2,160,218)(H,165,170)(H,169,221)(H,171,222)(H,172,219)(H,173,223)(H,174,240)(H,175,241)(H,176,239)(H,177,228)(H,178,243)(H,179,230)(H,180,232)(H,181,224)(H,182,234)(H,183,233)(H,184,226)(H,185,227)(H,186,225)(H,187,229)(H,188,242)(H,189,244)(H,190,220)(H,191,231)(H,192,235)(H,193,245)(H,194,211)(H,195,236)(H,196,238)(H,197,237)(H,212,213)(H,214,215)(H,216,217)(H4,161,162,166)(H4,163,164,167)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277063
(CHEMBL4163731)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSC1CC(=O)N(CCCCCCCCCCCC(O)=O)C1=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C166H244N42O52S2/c1-82(2)60-106(146(241)186-105(55-59-261-11)145(240)194-113(68-126(172)221)156(251)206-134(86(8)213)137(173)232)189-150(245)112(66-93-73-178-99-37-27-26-36-97(93)99)193-144(239)104(51-54-125(171)220)187-162(257)133(84(5)6)205-154(249)110(62-89-32-21-19-22-33-89)192-151(246)114(69-130(226)227)195-143(238)103(50-53-124(170)219)182-138(233)85(7)181-141(236)101(39-31-57-177-166(174)175)184-161(256)121(80-262-122-72-128(223)208(165(122)260)58-30-18-16-14-12-13-15-17-25-40-129(224)225)203-160(255)119(78-211)201-153(248)116(71-132(230)231)196-147(242)107(61-83(3)4)188-148(243)108(64-91-41-45-95(216)46-42-91)190-142(237)100(38-28-29-56-167)183-158(253)118(77-210)200-149(244)109(65-92-43-47-96(217)48-44-92)191-152(247)115(70-131(228)229)197-159(254)120(79-212)202-164(259)136(88(10)215)207-155(250)111(63-90-34-23-20-24-35-90)198-163(258)135(87(9)214)204-127(222)75-179-140(235)102(49-52-123(169)218)185-157(252)117(76-209)199-139(234)98(168)67-94-74-176-81-180-94/h19-24,26-27,32-37,41-48,73-74,81-88,98,100-122,133-136,178,209-217H,12-18,25,28-31,38-40,49-72,75-80,167-168H2,1-11H3,(H2,169,218)(H2,170,219)(H2,171,220)(H2,172,221)(H2,173,232)(H,176,180)(H,179,235)(H,181,236)(H,182,233)(H,183,253)(H,184,256)(H,185,252)(H,186,241)(H,187,257)(H,188,243)(H,189,245)(H,190,237)(H,191,247)(H,192,246)(H,193,239)(H,194,240)(H,195,238)(H,196,242)(H,197,254)(H,198,258)(H,199,234)(H,200,244)(H,201,248)(H,202,259)(H,203,255)(H,204,222)(H,205,249)(H,206,251)(H,207,250)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H4,174,175,177)/t85-,86+,87+,88+,98-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122?,133-,134-,135-,136-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277068
(CHEMBL4167169)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H219N41O48S2/c1-70(2)49-94(131(221)170-93(45-48-241-11)130(220)178-101(57-113(156)204)141(231)190-119(74(8)196)122(157)212)173-135(225)100(55-81-61-162-87-28-19-18-27-85(81)87)177-129(219)92(41-44-112(155)203)171-147(237)118(72(5)6)189-139(229)98(51-77-23-14-12-15-24-77)176-136(226)102(58-115(206)207)179-128(218)91(40-43-111(154)202)166-123(213)73(7)165-126(216)89(30-22-47-161-150(158)159)168-146(236)109(68-240)187-145(235)107(66-194)185-138(228)104(60-117(210)211)180-132(222)95(50-71(3)4)172-133(223)96(53-79-31-35-83(199)36-32-79)174-127(217)88(29-20-21-46-151)167-143(233)106(65-193)184-134(224)97(54-80-33-37-84(200)38-34-80)175-137(227)103(59-116(208)209)181-144(234)108(67-195)186-149(239)121(76(10)198)191-140(230)99(52-78-25-16-13-17-26-78)182-148(238)120(75(9)197)188-114(205)63-163-125(215)90(39-42-110(153)201)169-142(232)105(64-192)183-124(214)86(152)56-82-62-160-69-164-82/h12-19,23-28,31-38,61-62,69-76,86,88-109,118-121,162,192-200,240H,20-22,29-30,39-60,63-68,151-152H2,1-11H3,(H2,153,201)(H2,154,202)(H2,155,203)(H2,156,204)(H2,157,212)(H,160,164)(H,163,215)(H,165,216)(H,166,213)(H,167,233)(H,168,236)(H,169,232)(H,170,221)(H,171,237)(H,172,223)(H,173,225)(H,174,217)(H,175,227)(H,176,226)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,234)(H,182,238)(H,183,214)(H,184,224)(H,185,228)(H,186,239)(H,187,235)(H,188,205)(H,189,229)(H,190,231)(H,191,230)(H,206,207)(H,208,209)(H,210,211)(H4,158,159,161)/t73-,74+,75+,76+,86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,118-,119-,120-,121-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277069
(CHEMBL4161800)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C153H226N44O48S2/c1-72(2)51-96(133(227)176-95(46-50-247-10)132(226)184-103(59-115(159)210)143(237)196-121(75(7)202)124(160)218)179-137(231)102(57-82-63-168-88-28-18-17-27-86(82)88)183-131(225)94(42-45-114(158)209)177-149(243)120(74(5)6)195-141(235)100(53-78-23-13-11-14-24-78)182-138(232)104(60-117(212)213)185-130(224)93(41-44-113(157)208)175-148(242)111(70-246)193-129(223)91(31-22-49-167-153(163)164)171-127(221)90(30-21-48-166-152(161)162)173-146(240)109(68-200)191-140(234)106(62-119(216)217)186-134(228)97(52-73(3)4)178-135(229)98(55-80-32-36-84(205)37-33-80)180-128(222)89(29-19-20-47-154)172-145(239)108(67-199)190-136(230)99(56-81-34-38-85(206)39-35-81)181-139(233)105(61-118(214)215)187-147(241)110(69-201)192-151(245)123(77(9)204)197-142(236)101(54-79-25-15-12-16-26-79)188-150(244)122(76(8)203)194-116(211)65-169-126(220)92(40-43-112(156)207)174-144(238)107(66-198)189-125(219)87(155)58-83-64-165-71-170-83/h11-18,23-28,32-39,63-64,71-77,87,89-111,120-123,168,198-206,246H,19-22,29-31,40-62,65-70,154-155H2,1-10H3,(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,210)(H2,160,218)(H,165,170)(H,169,220)(H,171,221)(H,172,239)(H,173,240)(H,174,238)(H,175,242)(H,176,227)(H,177,243)(H,178,229)(H,179,231)(H,180,222)(H,181,233)(H,182,232)(H,183,225)(H,184,226)(H,185,224)(H,186,228)(H,187,241)(H,188,244)(H,189,219)(H,190,230)(H,191,234)(H,192,245)(H,193,223)(H,194,211)(H,195,235)(H,196,237)(H,197,236)(H,212,213)(H,214,215)(H,216,217)(H4,161,162,166)(H4,163,164,167)/t75-,76-,77-,87+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,120+,121+,122+,123+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277070
(CHEMBL4170976)Show SMILES CCCCCCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C173H261N45O50S2/c1-12-13-14-15-16-17-18-19-20-21-22-23-24-35-65-218-135(233)79-129(171(218)268)270-87-128(167(264)195-110(56-59-131(177)229)149(246)205-121(76-136(234)235)157(254)202-117(69-95-38-27-25-28-39-95)160(257)215-139(91(6)7)168(265)197-111(57-60-132(178)230)150(247)203-119(73-99-80-188-105-43-32-31-42-103(99)105)156(253)199-113(67-89(2)3)152(249)196-112(61-66-269-11)151(248)204-120(75-133(179)231)162(259)216-140(92(8)223)143(180)240)213-148(245)108(46-37-64-187-173(183)184)191-146(243)107(45-36-63-186-172(181)182)193-165(262)126(85-221)211-159(256)123(78-138(238)239)206-153(250)114(68-90(4)5)198-154(251)115(71-97-47-51-101(226)52-48-97)200-147(244)106(44-33-34-62-174)192-164(261)125(84-220)210-155(252)116(72-98-49-53-102(227)54-50-98)201-158(255)122(77-137(236)237)207-166(263)127(86-222)212-170(267)142(94(10)225)217-161(258)118(70-96-40-29-26-30-41-96)208-169(266)141(93(9)224)214-134(232)82-189-145(242)109(55-58-130(176)228)194-163(260)124(83-219)209-144(241)104(175)74-100-81-185-88-190-100/h25-32,38-43,47-54,80-81,88-94,104,106-129,139-142,188,219-227H,12-24,33-37,44-46,55-79,82-87,174-175H2,1-11H3,(H2,176,228)(H2,177,229)(H2,178,230)(H2,179,231)(H2,180,240)(H,185,190)(H,189,242)(H,191,243)(H,192,261)(H,193,262)(H,194,260)(H,195,264)(H,196,249)(H,197,265)(H,198,251)(H,199,253)(H,200,244)(H,201,255)(H,202,254)(H,203,247)(H,204,248)(H,205,246)(H,206,250)(H,207,263)(H,208,266)(H,209,241)(H,210,252)(H,211,256)(H,212,267)(H,213,245)(H,214,232)(H,215,257)(H,216,259)(H,217,258)(H,234,235)(H,236,237)(H,238,239)(H4,181,182,186)(H4,183,184,187)/t92-,93-,94-,104+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129?,139+,140+,141+,142+/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277071
(CHEMBL4160365)Show SMILES CCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C169H253N45O50S2/c1-12-13-14-15-16-17-18-19-20-31-61-214-131(229)75-125(167(214)264)266-83-124(163(260)191-106(52-55-127(173)225)145(242)201-117(72-132(230)231)153(250)198-113(65-91-34-23-21-24-35-91)156(253)211-135(87(6)7)164(261)193-107(53-56-128(174)226)146(243)199-115(69-95-76-184-101-39-28-27-38-99(95)101)152(249)195-109(63-85(2)3)148(245)192-108(57-62-265-11)147(244)200-116(71-129(175)227)158(255)212-136(88(8)219)139(176)236)209-144(241)104(42-33-60-183-169(179)180)187-142(239)103(41-32-59-182-168(177)178)189-161(258)122(81-217)207-155(252)119(74-134(234)235)202-149(246)110(64-86(4)5)194-150(247)111(67-93-43-47-97(222)48-44-93)196-143(240)102(40-29-30-58-170)188-160(257)121(80-216)206-151(248)112(68-94-45-49-98(223)50-46-94)197-154(251)118(73-133(232)233)203-162(259)123(82-218)208-166(263)138(90(10)221)213-157(254)114(66-92-36-25-22-26-37-92)204-165(262)137(89(9)220)210-130(228)78-185-141(238)105(51-54-126(172)224)190-159(256)120(79-215)205-140(237)100(171)70-96-77-181-84-186-96/h21-28,34-39,43-50,76-77,84-90,100,102-125,135-138,184,215-223H,12-20,29-33,40-42,51-75,78-83,170-171H2,1-11H3,(H2,172,224)(H2,173,225)(H2,174,226)(H2,175,227)(H2,176,236)(H,181,186)(H,185,238)(H,187,239)(H,188,257)(H,189,258)(H,190,256)(H,191,260)(H,192,245)(H,193,261)(H,194,247)(H,195,249)(H,196,240)(H,197,251)(H,198,250)(H,199,243)(H,200,244)(H,201,242)(H,202,246)(H,203,259)(H,204,262)(H,205,237)(H,206,248)(H,207,252)(H,208,263)(H,209,241)(H,210,228)(H,211,253)(H,212,255)(H,213,254)(H,230,231)(H,232,233)(H,234,235)(H4,177,178,182)(H4,179,180,183)/t88-,89-,90-,100+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125?,135+,136+,137+,138+/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277072
(CHEMBL4174404)Show SMILES CCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C163H241N45O50S2/c1-12-13-14-25-55-208-125(223)69-119(161(208)258)260-77-118(157(254)185-100(46-49-121(167)219)139(236)195-111(66-126(224)225)147(244)192-107(59-85-28-17-15-18-29-85)150(247)205-129(81(6)7)158(255)187-101(47-50-122(168)220)140(237)193-109(63-89-70-178-95-33-22-21-32-93(89)95)146(243)189-103(57-79(2)3)142(239)186-102(51-56-259-11)141(238)194-110(65-123(169)221)152(249)206-130(82(8)213)133(170)230)203-138(235)98(36-27-54-177-163(173)174)181-136(233)97(35-26-53-176-162(171)172)183-155(252)116(75-211)201-149(246)113(68-128(228)229)196-143(240)104(58-80(4)5)188-144(241)105(61-87-37-41-91(216)42-38-87)190-137(234)96(34-23-24-52-164)182-154(251)115(74-210)200-145(242)106(62-88-39-43-92(217)44-40-88)191-148(245)112(67-127(226)227)197-156(253)117(76-212)202-160(257)132(84(10)215)207-151(248)108(60-86-30-19-16-20-31-86)198-159(256)131(83(9)214)204-124(222)72-179-135(232)99(45-48-120(166)218)184-153(250)114(73-209)199-134(231)94(165)64-90-71-175-78-180-90/h15-22,28-33,37-44,70-71,78-84,94,96-119,129-132,178,209-217H,12-14,23-27,34-36,45-69,72-77,164-165H2,1-11H3,(H2,166,218)(H2,167,219)(H2,168,220)(H2,169,221)(H2,170,230)(H,175,180)(H,179,232)(H,181,233)(H,182,251)(H,183,252)(H,184,250)(H,185,254)(H,186,239)(H,187,255)(H,188,241)(H,189,243)(H,190,234)(H,191,245)(H,192,244)(H,193,237)(H,194,238)(H,195,236)(H,196,240)(H,197,253)(H,198,256)(H,199,231)(H,200,242)(H,201,246)(H,202,257)(H,203,235)(H,204,222)(H,205,247)(H,206,249)(H,207,248)(H,224,225)(H,226,227)(H,228,229)(H4,171,172,176)(H4,173,174,177)/t82-,83-,84-,94+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119?,129+,130+,131+,132+/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277059
(CHEMBL4177064)Show SMILES CCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C166H246N42O50S2/c1-13-14-15-16-17-18-19-20-21-32-59-208-129(223)73-123(165(208)258)260-81-122(161(254)184-102(41-33-58-177-166(174)175)141(234)181-86(8)138(231)182-104(51-54-125(170)219)143(236)195-115(70-130(224)225)151(244)192-111(63-90-34-24-22-25-35-90)154(247)205-133(85(6)7)162(255)187-105(52-55-126(171)220)144(237)193-113(67-94-74-178-100-39-29-28-38-98(94)100)150(243)189-107(61-83(2)3)146(239)186-106(56-60-259-12)145(238)194-114(69-127(172)221)156(249)206-134(87(9)213)137(173)230)203-160(253)120(79-211)201-153(246)117(72-132(228)229)196-147(240)108(62-84(4)5)188-148(241)109(65-92-42-46-96(216)47-43-92)190-142(235)101(40-30-31-57-167)183-158(251)119(78-210)200-149(242)110(66-93-44-48-97(217)49-45-93)191-152(245)116(71-131(226)227)197-159(252)121(80-212)202-164(257)136(89(11)215)207-155(248)112(64-91-36-26-23-27-37-91)198-163(256)135(88(10)214)204-128(222)76-179-140(233)103(50-53-124(169)218)185-157(250)118(77-209)199-139(232)99(168)68-95-75-176-82-180-95/h22-29,34-39,42-49,74-75,82-89,99,101-123,133-136,178,209-217H,13-21,30-33,40-41,50-73,76-81,167-168H2,1-12H3,(H2,169,218)(H2,170,219)(H2,171,220)(H2,172,221)(H2,173,230)(H,176,180)(H,179,233)(H,181,234)(H,182,231)(H,183,251)(H,184,254)(H,185,250)(H,186,239)(H,187,255)(H,188,241)(H,189,243)(H,190,235)(H,191,245)(H,192,244)(H,193,237)(H,194,238)(H,195,236)(H,196,240)(H,197,252)(H,198,256)(H,199,232)(H,200,242)(H,201,246)(H,202,257)(H,203,253)(H,204,222)(H,205,247)(H,206,249)(H,207,248)(H,224,225)(H,226,227)(H,228,229)(H4,174,175,177)/t86-,87+,88+,89+,99-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123?,133-,134-,135-,136-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277073
(CHEMBL4173061)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSC1CC(=O)N(CCCCCCCCCCCC(O)=O)C1=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C169H251N45O51S2/c1-84(2)63-109(149(247)193-108(57-62-266-11)148(246)201-116(71-128(175)226)159(257)212-136(88(8)218)139(176)237)196-153(251)115(69-95-76-184-101-38-27-26-37-99(95)101)200-147(245)107(53-56-127(174)225)194-164(262)135(86(5)6)211-157(255)113(65-91-33-21-19-22-34-91)199-154(252)117(72-132(231)232)202-146(244)106(52-55-126(173)224)188-140(238)87(7)187-143(241)103(40-31-59-182-168(177)178)189-144(242)104(41-32-60-183-169(179)180)191-163(261)123(82-267-124-75-130(228)214(167(124)265)61-30-18-16-14-12-13-15-17-25-42-131(229)230)209-156(254)119(74-134(235)236)203-150(248)110(64-85(3)4)195-151(249)111(67-93-43-47-97(221)48-44-93)197-145(243)102(39-28-29-58-170)190-161(259)121(80-216)207-152(250)112(68-94-45-49-98(222)50-46-94)198-155(253)118(73-133(233)234)204-162(260)122(81-217)208-166(264)138(90(10)220)213-158(256)114(66-92-35-23-20-24-36-92)205-165(263)137(89(9)219)210-129(227)78-185-142(240)105(51-54-125(172)223)192-160(258)120(79-215)206-141(239)100(171)70-96-77-181-83-186-96/h19-24,26-27,33-38,43-50,76-77,83-90,100,102-124,135-138,184,215-222H,12-18,25,28-32,39-42,51-75,78-82,170-171H2,1-11H3,(H2,172,223)(H2,173,224)(H2,174,225)(H2,175,226)(H2,176,237)(H,181,186)(H,185,240)(H,187,241)(H,188,238)(H,189,242)(H,190,259)(H,191,261)(H,192,258)(H,193,247)(H,194,262)(H,195,249)(H,196,251)(H,197,243)(H,198,253)(H,199,252)(H,200,245)(H,201,246)(H,202,244)(H,203,248)(H,204,260)(H,205,263)(H,206,239)(H,207,250)(H,208,264)(H,209,254)(H,210,227)(H,211,255)(H,212,257)(H,213,256)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H4,177,178,182)(H4,179,180,183)/t87-,88+,89+,90+,100-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124?,135-,136-,137-,138-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277074
(CHEMBL4166241)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C151H223N43O47S2/c1-71(2)50-95(131(223)174-94(45-49-243-11)130(222)181-102(58-113(156)206)141(233)193-119(75(8)199)122(157)214)176-135(227)101(56-82-62-165-88-29-19-18-28-86(82)88)180-146(238)110(69-242)190-147(239)118(73(5)6)192-139(231)99(52-78-24-14-12-15-25-78)179-136(228)103(59-115(208)209)182-129(221)93(42-44-112(155)205)169-123(215)74(7)168-126(218)90(31-22-47-163-150(158)159)170-127(219)91(32-23-48-164-151(160)161)172-144(236)108(67-197)188-138(230)105(61-117(212)213)183-132(224)96(51-72(3)4)175-133(225)97(54-80-33-37-84(202)38-34-80)177-128(220)89(30-20-21-46-152)171-143(235)107(66-196)187-134(226)98(55-81-35-39-85(203)40-36-81)178-137(229)104(60-116(210)211)184-145(237)109(68-198)189-149(241)121(77(10)201)194-140(232)100(53-79-26-16-13-17-27-79)185-148(240)120(76(9)200)191-114(207)64-166-125(217)92(41-43-111(154)204)173-142(234)106(65-195)186-124(216)87(153)57-83-63-162-70-167-83/h12-19,24-29,33-40,62-63,70-77,87,89-110,118-121,165,195-203,242H,20-23,30-32,41-61,64-69,152-153H2,1-11H3,(H2,154,204)(H2,155,205)(H2,156,206)(H2,157,214)(H,162,167)(H,166,217)(H,168,218)(H,169,215)(H,170,219)(H,171,235)(H,172,236)(H,173,234)(H,174,223)(H,175,225)(H,176,227)(H,177,220)(H,178,229)(H,179,228)(H,180,238)(H,181,222)(H,182,221)(H,183,224)(H,184,237)(H,185,240)(H,186,216)(H,187,226)(H,188,230)(H,189,241)(H,190,239)(H,191,207)(H,192,231)(H,193,233)(H,194,232)(H,208,209)(H,210,211)(H,212,213)(H4,158,159,163)(H4,160,161,164)/t74-,75+,76+,77+,87-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,118-,119-,120-,121-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277078
(CHEMBL4170727)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C151H222N44O48S2/c1-71(2)50-95(132(226)176-94(45-49-245-9)131(225)183-102(58-114(157)208)142(236)194-119(74(6)200)122(158)216)178-137(231)101(56-81-62-166-87-27-17-16-26-85(81)87)182-130(224)93(41-44-113(156)207)175-147(241)110(69-244)192-136(230)97(52-77-22-12-10-13-23-77)180-138(232)103(59-116(210)211)184-129(223)92(40-43-112(155)206)170-123(217)73(5)169-126(220)89(29-20-47-164-150(159)160)171-127(221)90(30-21-48-165-151(161)162)173-145(239)108(67-198)190-140(234)105(61-118(214)215)185-133(227)96(51-72(3)4)177-134(228)98(54-79-31-35-83(203)36-32-79)179-128(222)88(28-18-19-46-152)172-144(238)107(66-197)189-135(229)99(55-80-33-37-84(204)38-34-80)181-139(233)104(60-117(212)213)186-146(240)109(68-199)191-149(243)121(76(8)202)195-141(235)100(53-78-24-14-11-15-25-78)187-148(242)120(75(7)201)193-115(209)64-167-125(219)91(39-42-111(154)205)174-143(237)106(65-196)188-124(218)86(153)57-82-63-163-70-168-82/h10-17,22-27,31-38,62-63,70-76,86,88-110,119-121,166,196-204,244H,18-21,28-30,39-61,64-69,152-153H2,1-9H3,(H2,154,205)(H2,155,206)(H2,156,207)(H2,157,208)(H2,158,216)(H,163,168)(H,167,219)(H,169,220)(H,170,217)(H,171,221)(H,172,238)(H,173,239)(H,174,237)(H,175,241)(H,176,226)(H,177,228)(H,178,231)(H,179,222)(H,180,232)(H,181,233)(H,182,224)(H,183,225)(H,184,223)(H,185,227)(H,186,240)(H,187,242)(H,188,218)(H,189,229)(H,190,234)(H,191,243)(H,192,230)(H,193,209)(H,194,236)(H,195,235)(H,210,211)(H,212,213)(H,214,215)(H4,159,160,164)(H4,161,162,165)/t73-,74+,75+,76+,86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,119-,120-,121-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.75 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277079
(CHEMBL4162789)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C147H222N44O48S2/c1-67(2)47-91(128(222)171-90(42-46-241-11)127(221)178-97(54-109(153)204)137(231)190-115(71(8)196)118(154)212)174-132(226)96(52-77-58-162-83-24-16-15-23-81(77)83)177-126(220)89(38-41-108(152)203)172-143(237)114(69(5)6)189-142(236)105(65-240)187-135(229)100(57-113(210)211)179-125(219)88(37-40-107(151)202)166-119(213)70(7)165-122(216)85(26-19-44-160-146(155)156)167-123(217)86(27-20-45-161-147(157)158)169-140(234)103(63-194)185-134(228)99(56-112(208)209)180-129(223)92(48-68(3)4)173-130(224)93(50-75-28-32-79(199)33-29-75)175-124(218)84(25-17-18-43-148)168-139(233)102(62-193)184-131(225)94(51-76-30-34-80(200)35-31-76)176-133(227)98(55-111(206)207)181-141(235)104(64-195)186-145(239)117(73(10)198)191-136(230)95(49-74-21-13-12-14-22-74)182-144(238)116(72(9)197)188-110(205)60-163-121(215)87(36-39-106(150)201)170-138(232)101(61-192)183-120(214)82(149)53-78-59-159-66-164-78/h12-16,21-24,28-35,58-59,66-73,82,84-105,114-117,162,192-200,240H,17-20,25-27,36-57,60-65,148-149H2,1-11H3,(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,204)(H2,154,212)(H,159,164)(H,163,215)(H,165,216)(H,166,213)(H,167,217)(H,168,233)(H,169,234)(H,170,232)(H,171,222)(H,172,237)(H,173,224)(H,174,226)(H,175,218)(H,176,227)(H,177,220)(H,178,221)(H,179,219)(H,180,223)(H,181,235)(H,182,238)(H,183,214)(H,184,225)(H,185,228)(H,186,239)(H,187,229)(H,188,205)(H,189,236)(H,190,231)(H,191,230)(H,206,207)(H,208,209)(H,210,211)(H4,155,156,160)(H4,157,158,161)/t70-,71+,72+,73+,82-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,114-,115-,116-,117-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 123 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277069
(CHEMBL4161800)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C153H226N44O48S2/c1-72(2)51-96(133(227)176-95(46-50-247-10)132(226)184-103(59-115(159)210)143(237)196-121(75(7)202)124(160)218)179-137(231)102(57-82-63-168-88-28-18-17-27-86(82)88)183-131(225)94(42-45-114(158)209)177-149(243)120(74(5)6)195-141(235)100(53-78-23-13-11-14-24-78)182-138(232)104(60-117(212)213)185-130(224)93(41-44-113(157)208)175-148(242)111(70-246)193-129(223)91(31-22-49-167-153(163)164)171-127(221)90(30-21-48-166-152(161)162)173-146(240)109(68-200)191-140(234)106(62-119(216)217)186-134(228)97(52-73(3)4)178-135(229)98(55-80-32-36-84(205)37-33-80)180-128(222)89(29-19-20-47-154)172-145(239)108(67-199)190-136(230)99(56-81-34-38-85(206)39-35-81)181-139(233)105(61-118(214)215)187-147(241)110(69-201)192-151(245)123(77(9)204)197-142(236)101(54-79-25-15-12-16-26-79)188-150(244)122(76(8)203)194-116(211)65-169-126(220)92(40-43-112(156)207)174-144(238)107(66-198)189-125(219)87(155)58-83-64-165-71-170-83/h11-18,23-28,32-39,63-64,71-77,87,89-111,120-123,168,198-206,246H,19-22,29-31,40-62,65-70,154-155H2,1-10H3,(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,210)(H2,160,218)(H,165,170)(H,169,220)(H,171,221)(H,172,239)(H,173,240)(H,174,238)(H,175,242)(H,176,227)(H,177,243)(H,178,229)(H,179,231)(H,180,222)(H,181,233)(H,182,232)(H,183,225)(H,184,226)(H,185,224)(H,186,228)(H,187,241)(H,188,244)(H,189,219)(H,190,230)(H,191,234)(H,192,245)(H,193,223)(H,194,211)(H,195,235)(H,196,237)(H,197,236)(H,212,213)(H,214,215)(H,216,217)(H4,161,162,166)(H4,163,164,167)/t75-,76-,77-,87+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,120+,121+,122+,123+/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277080
(CHEMBL4172444)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H219N41O48S2/c1-70(2)49-94(131(221)170-93(45-48-241-11)130(220)178-101(57-113(156)204)141(231)190-119(74(8)196)122(157)212)173-135(225)100(55-81-61-162-87-28-19-18-27-85(81)87)177-129(219)92(41-44-112(155)203)171-147(237)118(72(5)6)189-139(229)98(51-77-23-14-12-15-24-77)176-136(226)102(58-115(206)207)179-128(218)91(40-43-111(154)202)166-123(213)73(7)165-146(236)109(68-240)187-127(217)89(30-22-47-161-150(158)159)168-144(234)107(66-194)185-138(228)104(60-117(210)211)180-132(222)95(50-71(3)4)172-133(223)96(53-79-31-35-83(199)36-32-79)174-126(216)88(29-20-21-46-151)167-143(233)106(65-193)184-134(224)97(54-80-33-37-84(200)38-34-80)175-137(227)103(59-116(208)209)181-145(235)108(67-195)186-149(239)121(76(10)198)191-140(230)99(52-78-25-16-13-17-26-78)182-148(238)120(75(9)197)188-114(205)63-163-125(215)90(39-42-110(153)201)169-142(232)105(64-192)183-124(214)86(152)56-82-62-160-69-164-82/h12-19,23-28,31-38,61-62,69-76,86,88-109,118-121,162,192-200,240H,20-22,29-30,39-60,63-68,151-152H2,1-11H3,(H2,153,201)(H2,154,202)(H2,155,203)(H2,156,204)(H2,157,212)(H,160,164)(H,163,215)(H,165,236)(H,166,213)(H,167,233)(H,168,234)(H,169,232)(H,170,221)(H,171,237)(H,172,223)(H,173,225)(H,174,216)(H,175,227)(H,176,226)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,235)(H,182,238)(H,183,214)(H,184,224)(H,185,228)(H,186,239)(H,187,217)(H,188,205)(H,189,229)(H,190,231)(H,191,230)(H,206,207)(H,208,209)(H,210,211)(H4,158,159,161)/t73-,74+,75+,76+,86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,118-,119-,120-,121-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277061
(CHEMBL4159256)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C153H226N44O47S2/c1-72(2)52-97(134(227)177-96(47-51-246-11)133(226)185-104(60-115(159)209)144(237)196-121(76(8)201)124(160)217)180-138(231)103(58-83-64-168-89-29-19-18-28-87(83)89)184-132(225)95(43-46-114(158)208)178-149(242)120(74(5)6)195-142(235)101(54-79-24-14-12-15-25-79)183-139(232)105(61-117(211)212)186-131(224)94(42-45-113(157)207)172-125(218)75(7)171-128(221)91(31-22-49-166-152(161)162)173-129(222)92(32-23-50-167-153(163)164)175-148(241)111(70-245)193-141(234)107(63-119(215)216)187-135(228)98(53-73(3)4)179-136(229)99(56-81-33-37-85(204)38-34-81)181-130(223)90(30-20-21-48-154)174-146(239)109(68-199)191-137(230)100(57-82-35-39-86(205)40-36-82)182-140(233)106(62-118(213)214)188-147(240)110(69-200)192-151(244)123(78(10)203)197-143(236)102(55-80-26-16-13-17-27-80)189-150(243)122(77(9)202)194-116(210)66-169-127(220)93(41-44-112(156)206)176-145(238)108(67-198)190-126(219)88(155)59-84-65-165-71-170-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,168,198-205,245H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H2,160,217)(H,165,170)(H,169,220)(H,171,221)(H,172,218)(H,173,222)(H,174,239)(H,175,241)(H,176,238)(H,177,227)(H,178,242)(H,179,229)(H,180,231)(H,181,223)(H,182,233)(H,183,232)(H,184,225)(H,185,226)(H,186,224)(H,187,228)(H,188,240)(H,189,243)(H,190,219)(H,191,230)(H,192,244)(H,193,234)(H,194,210)(H,195,235)(H,196,237)(H,197,236)(H,211,212)(H,213,214)(H,215,216)(H4,161,162,166)(H4,163,164,167)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50266668
(CHEMBL4098545)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(O)=O |r| Show InChI InChI=1S/C192H295N61O60S/c1-15-92(8)149(184(308)220-94(10)188(312)313)251-177(301)128(76-142(201)268)240-171(295)127(75-141(200)267)238-161(285)114(43-31-64-215-192(209)210)224-170(294)126(74-140(199)266)237-160(284)113(42-30-63-214-191(207)208)223-157(281)110(39-25-27-60-194)229-186(310)151(96(12)259)253-178(302)129(77-143(202)269)239-164(288)118(58-65-314-14)228-165(289)119(66-89(2)3)232-169(293)125(72-102-81-216-108-37-23-22-36-106(102)108)236-163(287)117(54-57-139(198)265)230-183(307)148(91(6)7)250-175(299)123(68-98-32-18-16-19-33-98)235-172(296)130(78-145(271)272)241-162(286)116(53-56-138(197)264)221-153(277)93(9)219-156(280)111(40-28-61-212-189(203)204)222-158(282)112(41-29-62-213-190(205)206)226-181(305)135(86-256)247-174(298)132(80-147(275)276)242-166(290)120(67-90(4)5)231-167(291)121(70-100-44-48-104(261)49-45-100)233-159(283)109(38-24-26-59-193)225-180(304)134(85-255)246-168(292)122(71-101-46-50-105(262)51-47-101)234-173(297)131(79-146(273)274)243-182(306)136(87-257)248-187(311)152(97(13)260)252-176(300)124(69-99-34-20-17-21-35-99)244-185(309)150(95(11)258)249-144(270)83-217-155(279)115(52-55-137(196)263)227-179(303)133(84-254)245-154(278)107(195)73-103-82-211-88-218-103/h16-23,32-37,44-51,81-82,88-97,107,109-136,148-152,216,254-262H,15,24-31,38-43,52-80,83-87,193-195H2,1-14H3,(H2,196,263)(H2,197,264)(H2,198,265)(H2,199,266)(H2,200,267)(H2,201,268)(H2,202,269)(H,211,218)(H,217,279)(H,219,280)(H,220,308)(H,221,277)(H,222,282)(H,223,281)(H,224,294)(H,225,304)(H,226,305)(H,227,303)(H,228,289)(H,229,310)(H,230,307)(H,231,291)(H,232,293)(H,233,283)(H,234,297)(H,235,296)(H,236,287)(H,237,284)(H,238,285)(H,239,288)(H,240,295)(H,241,286)(H,242,290)(H,243,306)(H,244,309)(H,245,278)(H,246,292)(H,247,298)(H,248,311)(H,249,270)(H,250,299)(H,251,301)(H,252,300)(H,253,302)(H,271,272)(H,273,274)(H,275,276)(H,312,313)(H4,203,204,212)(H4,205,206,213)(H4,207,208,214)(H4,209,210,215)/t92-,93-,94-,95+,96+,97+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,148-,149-,150-,151-,152-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277062
(CHEMBL4175452)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C153H226N44O48S/c1-72(2)52-97(134(228)177-96(47-51-246-11)133(227)185-104(60-115(159)210)144(238)196-121(76(8)202)124(160)218)180-138(232)103(58-83-64-168-89-29-19-18-28-87(83)89)184-132(226)95(43-46-114(158)209)178-149(243)120(74(5)6)195-142(236)101(54-79-24-14-12-15-25-79)183-139(233)105(61-117(212)213)186-131(225)94(42-45-113(157)208)172-125(219)75(7)171-128(222)91(31-22-49-166-152(161)162)173-129(223)92(32-23-50-167-153(163)164)175-147(241)110(69-200)192-141(235)107(63-119(216)217)187-135(229)98(53-73(3)4)179-136(230)99(56-81-33-37-85(205)38-34-81)181-130(224)90(30-20-21-48-154)174-146(240)109(68-199)191-137(231)100(57-82-35-39-86(206)40-36-82)182-140(234)106(62-118(214)215)188-148(242)111(70-201)193-151(245)123(78(10)204)197-143(237)102(55-80-26-16-13-17-27-80)189-150(244)122(77(9)203)194-116(211)66-169-127(221)93(41-44-112(156)207)176-145(239)108(67-198)190-126(220)88(155)59-84-65-165-71-170-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,168,198-206H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,210)(H2,160,218)(H,165,170)(H,169,221)(H,171,222)(H,172,219)(H,173,223)(H,174,240)(H,175,241)(H,176,239)(H,177,228)(H,178,243)(H,179,230)(H,180,232)(H,181,224)(H,182,234)(H,183,233)(H,184,226)(H,185,227)(H,186,225)(H,187,229)(H,188,242)(H,189,244)(H,190,220)(H,191,231)(H,192,235)(H,193,245)(H,194,211)(H,195,236)(H,196,238)(H,197,237)(H,212,213)(H,214,215)(H,216,217)(H4,161,162,166)(H4,163,164,167)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277070
(CHEMBL4170976)Show SMILES CCCCCCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C173H261N45O50S2/c1-12-13-14-15-16-17-18-19-20-21-22-23-24-35-65-218-135(233)79-129(171(218)268)270-87-128(167(264)195-110(56-59-131(177)229)149(246)205-121(76-136(234)235)157(254)202-117(69-95-38-27-25-28-39-95)160(257)215-139(91(6)7)168(265)197-111(57-60-132(178)230)150(247)203-119(73-99-80-188-105-43-32-31-42-103(99)105)156(253)199-113(67-89(2)3)152(249)196-112(61-66-269-11)151(248)204-120(75-133(179)231)162(259)216-140(92(8)223)143(180)240)213-148(245)108(46-37-64-187-173(183)184)191-146(243)107(45-36-63-186-172(181)182)193-165(262)126(85-221)211-159(256)123(78-138(238)239)206-153(250)114(68-90(4)5)198-154(251)115(71-97-47-51-101(226)52-48-97)200-147(244)106(44-33-34-62-174)192-164(261)125(84-220)210-155(252)116(72-98-49-53-102(227)54-50-98)201-158(255)122(77-137(236)237)207-166(263)127(86-222)212-170(267)142(94(10)225)217-161(258)118(70-96-40-29-26-30-41-96)208-169(266)141(93(9)224)214-134(232)82-189-145(242)109(55-58-130(176)228)194-163(260)124(83-219)209-144(241)104(175)74-100-81-185-88-190-100/h25-32,38-43,47-54,80-81,88-94,104,106-129,139-142,188,219-227H,12-24,33-37,44-46,55-79,82-87,174-175H2,1-11H3,(H2,176,228)(H2,177,229)(H2,178,230)(H2,179,231)(H2,180,240)(H,185,190)(H,189,242)(H,191,243)(H,192,261)(H,193,262)(H,194,260)(H,195,264)(H,196,249)(H,197,265)(H,198,251)(H,199,253)(H,200,244)(H,201,255)(H,202,254)(H,203,247)(H,204,248)(H,205,246)(H,206,250)(H,207,263)(H,208,266)(H,209,241)(H,210,252)(H,211,256)(H,212,267)(H,213,245)(H,214,232)(H,215,257)(H,216,259)(H,217,258)(H,234,235)(H,236,237)(H,238,239)(H4,181,182,186)(H4,183,184,187)/t92-,93-,94-,104+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129?,139+,140+,141+,142+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 112 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277071
(CHEMBL4160365)Show SMILES CCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C169H253N45O50S2/c1-12-13-14-15-16-17-18-19-20-31-61-214-131(229)75-125(167(214)264)266-83-124(163(260)191-106(52-55-127(173)225)145(242)201-117(72-132(230)231)153(250)198-113(65-91-34-23-21-24-35-91)156(253)211-135(87(6)7)164(261)193-107(53-56-128(174)226)146(243)199-115(69-95-76-184-101-39-28-27-38-99(95)101)152(249)195-109(63-85(2)3)148(245)192-108(57-62-265-11)147(244)200-116(71-129(175)227)158(255)212-136(88(8)219)139(176)236)209-144(241)104(42-33-60-183-169(179)180)187-142(239)103(41-32-59-182-168(177)178)189-161(258)122(81-217)207-155(252)119(74-134(234)235)202-149(246)110(64-86(4)5)194-150(247)111(67-93-43-47-97(222)48-44-93)196-143(240)102(40-29-30-58-170)188-160(257)121(80-216)206-151(248)112(68-94-45-49-98(223)50-46-94)197-154(251)118(73-133(232)233)203-162(259)123(82-218)208-166(263)138(90(10)221)213-157(254)114(66-92-36-25-22-26-37-92)204-165(262)137(89(9)220)210-130(228)78-185-141(238)105(51-54-126(172)224)190-159(256)120(79-215)205-140(237)100(171)70-96-77-181-84-186-96/h21-28,34-39,43-50,76-77,84-90,100,102-125,135-138,184,215-223H,12-20,29-33,40-42,51-75,78-83,170-171H2,1-11H3,(H2,172,224)(H2,173,225)(H2,174,226)(H2,175,227)(H2,176,236)(H,181,186)(H,185,238)(H,187,239)(H,188,257)(H,189,258)(H,190,256)(H,191,260)(H,192,245)(H,193,261)(H,194,247)(H,195,249)(H,196,240)(H,197,251)(H,198,250)(H,199,243)(H,200,244)(H,201,242)(H,202,246)(H,203,259)(H,204,262)(H,205,237)(H,206,248)(H,207,252)(H,208,263)(H,209,241)(H,210,228)(H,211,253)(H,212,255)(H,213,254)(H,230,231)(H,232,233)(H,234,235)(H4,177,178,182)(H4,179,180,183)/t88-,89-,90-,100+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125?,135+,136+,137+,138+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277063
(CHEMBL4163731)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSC1CC(=O)N(CCCCCCCCCCCC(O)=O)C1=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C166H244N42O52S2/c1-82(2)60-106(146(241)186-105(55-59-261-11)145(240)194-113(68-126(172)221)156(251)206-134(86(8)213)137(173)232)189-150(245)112(66-93-73-178-99-37-27-26-36-97(93)99)193-144(239)104(51-54-125(171)220)187-162(257)133(84(5)6)205-154(249)110(62-89-32-21-19-22-33-89)192-151(246)114(69-130(226)227)195-143(238)103(50-53-124(170)219)182-138(233)85(7)181-141(236)101(39-31-57-177-166(174)175)184-161(256)121(80-262-122-72-128(223)208(165(122)260)58-30-18-16-14-12-13-15-17-25-40-129(224)225)203-160(255)119(78-211)201-153(248)116(71-132(230)231)196-147(242)107(61-83(3)4)188-148(243)108(64-91-41-45-95(216)46-42-91)190-142(237)100(38-28-29-56-167)183-158(253)118(77-210)200-149(244)109(65-92-43-47-96(217)48-44-92)191-152(247)115(70-131(228)229)197-159(254)120(79-212)202-164(259)136(88(10)215)207-155(250)111(63-90-34-23-20-24-35-90)198-163(258)135(87(9)214)204-127(222)75-179-140(235)102(49-52-123(169)218)185-157(252)117(76-209)199-139(234)98(168)67-94-74-176-81-180-94/h19-24,26-27,32-37,41-48,73-74,81-88,98,100-122,133-136,178,209-217H,12-18,25,28-31,38-40,49-72,75-80,167-168H2,1-11H3,(H2,169,218)(H2,170,219)(H2,171,220)(H2,172,221)(H2,173,232)(H,176,180)(H,179,235)(H,181,236)(H,182,233)(H,183,253)(H,184,256)(H,185,252)(H,186,241)(H,187,257)(H,188,243)(H,189,245)(H,190,237)(H,191,247)(H,192,246)(H,193,239)(H,194,240)(H,195,238)(H,196,242)(H,197,254)(H,198,258)(H,199,234)(H,200,244)(H,201,248)(H,202,259)(H,203,255)(H,204,222)(H,205,249)(H,206,251)(H,207,250)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H4,174,175,177)/t85-,86+,87+,88+,98-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122?,133-,134-,135-,136-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277081
(CHEMBL4162383)Show SMILES CCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C160H234N42O50S2/c1-13-14-15-26-53-202-123(217)67-117(159(202)252)254-75-116(155(248)178-96(35-27-52-171-160(168)169)135(228)175-80(8)132(225)176-98(45-48-119(164)213)137(230)189-109(64-124(218)219)145(238)186-105(57-84-28-18-16-19-29-84)148(241)199-127(79(6)7)156(249)181-99(46-49-120(165)214)138(231)187-107(61-88-68-172-94-33-23-22-32-92(88)94)144(237)183-101(55-77(2)3)140(233)180-100(50-54-253-12)139(232)188-108(63-121(166)215)150(243)200-128(81(9)207)131(167)224)197-154(247)114(73-205)195-147(240)111(66-126(222)223)190-141(234)102(56-78(4)5)182-142(235)103(59-86-36-40-90(210)41-37-86)184-136(229)95(34-24-25-51-161)177-152(245)113(72-204)194-143(236)104(60-87-38-42-91(211)43-39-87)185-146(239)110(65-125(220)221)191-153(246)115(74-206)196-158(251)130(83(11)209)201-149(242)106(58-85-30-20-17-21-31-85)192-157(250)129(82(10)208)198-122(216)70-173-134(227)97(44-47-118(163)212)179-151(244)112(71-203)193-133(226)93(162)62-89-69-170-76-174-89/h16-23,28-33,36-43,68-69,76-83,93,95-117,127-130,172,203-211H,13-15,24-27,34-35,44-67,70-75,161-162H2,1-12H3,(H2,163,212)(H2,164,213)(H2,165,214)(H2,166,215)(H2,167,224)(H,170,174)(H,173,227)(H,175,228)(H,176,225)(H,177,245)(H,178,248)(H,179,244)(H,180,233)(H,181,249)(H,182,235)(H,183,237)(H,184,229)(H,185,239)(H,186,238)(H,187,231)(H,188,232)(H,189,230)(H,190,234)(H,191,246)(H,192,250)(H,193,226)(H,194,236)(H,195,240)(H,196,251)(H,197,247)(H,198,216)(H,199,241)(H,200,243)(H,201,242)(H,218,219)(H,220,221)(H,222,223)(H4,168,169,171)/t80-,81+,82+,83+,93-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117?,127-,128-,129-,130-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277073
(CHEMBL4173061)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CSC1CC(=O)N(CCCCCCCCCCCC(O)=O)C1=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C169H251N45O51S2/c1-84(2)63-109(149(247)193-108(57-62-266-11)148(246)201-116(71-128(175)226)159(257)212-136(88(8)218)139(176)237)196-153(251)115(69-95-76-184-101-38-27-26-37-99(95)101)200-147(245)107(53-56-127(174)225)194-164(262)135(86(5)6)211-157(255)113(65-91-33-21-19-22-34-91)199-154(252)117(72-132(231)232)202-146(244)106(52-55-126(173)224)188-140(238)87(7)187-143(241)103(40-31-59-182-168(177)178)189-144(242)104(41-32-60-183-169(179)180)191-163(261)123(82-267-124-75-130(228)214(167(124)265)61-30-18-16-14-12-13-15-17-25-42-131(229)230)209-156(254)119(74-134(235)236)203-150(248)110(64-85(3)4)195-151(249)111(67-93-43-47-97(221)48-44-93)197-145(243)102(39-28-29-58-170)190-161(259)121(80-216)207-152(250)112(68-94-45-49-98(222)50-46-94)198-155(253)118(73-133(233)234)204-162(260)122(81-217)208-166(264)138(90(10)220)213-158(256)114(66-92-35-23-20-24-36-92)205-165(263)137(89(9)219)210-129(227)78-185-142(240)105(51-54-125(172)223)192-160(258)120(79-215)206-141(239)100(171)70-96-77-181-83-186-96/h19-24,26-27,33-38,43-50,76-77,83-90,100,102-124,135-138,184,215-222H,12-18,25,28-32,39-42,51-75,78-82,170-171H2,1-11H3,(H2,172,223)(H2,173,224)(H2,174,225)(H2,175,226)(H2,176,237)(H,181,186)(H,185,240)(H,187,241)(H,188,238)(H,189,242)(H,190,259)(H,191,261)(H,192,258)(H,193,247)(H,194,262)(H,195,249)(H,196,251)(H,197,243)(H,198,253)(H,199,252)(H,200,245)(H,201,246)(H,202,244)(H,203,248)(H,204,260)(H,205,263)(H,206,239)(H,207,250)(H,208,264)(H,209,254)(H,210,227)(H,211,255)(H,212,257)(H,213,256)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H4,177,178,182)(H4,179,180,183)/t87-,88+,89+,90+,100-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124?,135-,136-,137-,138-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.860 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277082
(CHEMBL4159003)Show SMILES CCCCCCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C173H261N45O49S2/c1-13-14-15-16-17-18-19-20-21-22-23-24-25-36-66-218-135(232)80-129(171(218)267)269-87-128(167(263)195-109(47-38-65-187-173(183)184)148(244)193-108(46-37-64-186-172(181)182)147(243)191-92(8)144(240)192-111(57-60-131(177)228)150(246)206-122(77-136(233)234)158(254)203-118(70-96-39-28-26-29-40-96)161(257)215-139(91(6)7)168(264)198-112(58-61-132(178)229)151(247)204-120(74-100-81-188-106-44-33-32-43-104(100)106)157(253)200-114(68-89(2)3)153(249)197-113(62-67-268-12)152(248)205-121(76-133(179)230)163(259)216-140(93(9)222)143(180)239)213-160(256)124(79-138(237)238)207-154(250)115(69-90(4)5)199-155(251)116(72-98-48-52-102(225)53-49-98)201-149(245)107(45-34-35-63-174)194-165(261)126(85-220)211-156(252)117(73-99-50-54-103(226)55-51-99)202-159(255)123(78-137(235)236)208-166(262)127(86-221)212-170(266)142(95(11)224)217-162(258)119(71-97-41-30-27-31-42-97)209-169(265)141(94(10)223)214-134(231)83-189-146(242)110(56-59-130(176)227)196-164(260)125(84-219)210-145(241)105(175)75-101-82-185-88-190-101/h26-33,39-44,48-55,81-82,88-95,105,107-129,139-142,188,219-226H,13-25,34-38,45-47,56-80,83-87,174-175H2,1-12H3,(H2,176,227)(H2,177,228)(H2,178,229)(H2,179,230)(H2,180,239)(H,185,190)(H,189,242)(H,191,243)(H,192,240)(H,193,244)(H,194,261)(H,195,263)(H,196,260)(H,197,249)(H,198,264)(H,199,251)(H,200,253)(H,201,245)(H,202,255)(H,203,254)(H,204,247)(H,205,248)(H,206,246)(H,207,250)(H,208,262)(H,209,265)(H,210,241)(H,211,252)(H,212,266)(H,213,256)(H,214,231)(H,215,257)(H,216,259)(H,217,258)(H,233,234)(H,235,236)(H,237,238)(H4,181,182,186)(H4,183,184,187)/t92-,93+,94+,95+,105-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129?,139-,140-,141-,142-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 88 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277057
(CHEMBL4174154)Show SMILES CCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C163H241N45O49S2/c1-13-14-15-26-56-208-125(222)70-119(161(208)257)259-77-118(157(253)185-99(37-28-55-177-163(173)174)138(234)183-98(36-27-54-176-162(171)172)137(233)181-82(8)134(230)182-101(47-50-121(167)218)140(236)196-112(67-126(223)224)148(244)193-108(60-86-29-18-16-19-30-86)151(247)205-129(81(6)7)158(254)188-102(48-51-122(168)219)141(237)194-110(64-90-71-178-96-34-23-22-33-94(90)96)147(243)190-104(58-79(2)3)143(239)187-103(52-57-258-12)142(238)195-111(66-123(169)220)153(249)206-130(83(9)212)133(170)229)203-150(246)114(69-128(227)228)197-144(240)105(59-80(4)5)189-145(241)106(62-88-38-42-92(215)43-39-88)191-139(235)97(35-24-25-53-164)184-155(251)116(75-210)201-146(242)107(63-89-40-44-93(216)45-41-89)192-149(245)113(68-127(225)226)198-156(252)117(76-211)202-160(256)132(85(11)214)207-152(248)109(61-87-31-20-17-21-32-87)199-159(255)131(84(10)213)204-124(221)73-179-136(232)100(46-49-120(166)217)186-154(250)115(74-209)200-135(231)95(165)65-91-72-175-78-180-91/h16-23,29-34,38-45,71-72,78-85,95,97-119,129-132,178,209-216H,13-15,24-28,35-37,46-70,73-77,164-165H2,1-12H3,(H2,166,217)(H2,167,218)(H2,168,219)(H2,169,220)(H2,170,229)(H,175,180)(H,179,232)(H,181,233)(H,182,230)(H,183,234)(H,184,251)(H,185,253)(H,186,250)(H,187,239)(H,188,254)(H,189,241)(H,190,243)(H,191,235)(H,192,245)(H,193,244)(H,194,237)(H,195,238)(H,196,236)(H,197,240)(H,198,252)(H,199,255)(H,200,231)(H,201,242)(H,202,256)(H,203,246)(H,204,221)(H,205,247)(H,206,249)(H,207,248)(H,223,224)(H,225,226)(H,227,228)(H4,171,172,176)(H4,173,174,177)/t82-,83+,84+,85+,95-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119?,129-,130-,131-,132-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277074
(CHEMBL4166241)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C151H223N43O47S2/c1-71(2)50-95(131(223)174-94(45-49-243-11)130(222)181-102(58-113(156)206)141(233)193-119(75(8)199)122(157)214)176-135(227)101(56-82-62-165-88-29-19-18-28-86(82)88)180-146(238)110(69-242)190-147(239)118(73(5)6)192-139(231)99(52-78-24-14-12-15-25-78)179-136(228)103(59-115(208)209)182-129(221)93(42-44-112(155)205)169-123(215)74(7)168-126(218)90(31-22-47-163-150(158)159)170-127(219)91(32-23-48-164-151(160)161)172-144(236)108(67-197)188-138(230)105(61-117(212)213)183-132(224)96(51-72(3)4)175-133(225)97(54-80-33-37-84(202)38-34-80)177-128(220)89(30-20-21-46-152)171-143(235)107(66-196)187-134(226)98(55-81-35-39-85(203)40-36-81)178-137(229)104(60-116(210)211)184-145(237)109(68-198)189-149(241)121(77(10)201)194-140(232)100(53-79-26-16-13-17-27-79)185-148(240)120(76(9)200)191-114(207)64-166-125(217)92(41-43-111(154)204)173-142(234)106(65-195)186-124(216)87(153)57-83-63-162-70-167-83/h12-19,24-29,33-40,62-63,70-77,87,89-110,118-121,165,195-203,242H,20-23,30-32,41-61,64-69,152-153H2,1-11H3,(H2,154,204)(H2,155,205)(H2,156,206)(H2,157,214)(H,162,167)(H,166,217)(H,168,218)(H,169,215)(H,170,219)(H,171,235)(H,172,236)(H,173,234)(H,174,223)(H,175,225)(H,176,227)(H,177,220)(H,178,229)(H,179,228)(H,180,238)(H,181,222)(H,182,221)(H,183,224)(H,184,237)(H,185,240)(H,186,216)(H,187,226)(H,188,230)(H,189,241)(H,190,239)(H,191,207)(H,192,231)(H,193,233)(H,194,232)(H,208,209)(H,210,211)(H,212,213)(H4,158,159,163)(H4,160,161,164)/t74-,75+,76+,77+,87-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,118-,119-,120-,121-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277083
(CHEMBL4159426)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C151H223N43O47S2/c1-71(2)50-95(131(223)173-94(45-49-243-11)130(222)181-102(58-113(156)206)141(233)193-119(75(8)199)122(157)214)176-135(227)101(56-82-62-165-88-29-19-18-28-86(82)88)180-129(221)93(42-44-112(155)205)174-147(239)118(73(5)6)192-139(231)99(52-78-24-14-12-15-25-78)179-137(229)104(60-116(210)211)184-146(238)110(69-242)190-123(215)74(7)168-126(218)90(31-22-47-163-150(158)159)169-127(219)91(32-23-48-164-151(160)161)171-144(236)108(67-197)188-138(230)105(61-117(212)213)182-132(224)96(51-72(3)4)175-133(225)97(54-80-33-37-84(202)38-34-80)177-128(220)89(30-20-21-46-152)170-143(235)107(66-196)187-134(226)98(55-81-35-39-85(203)40-36-81)178-136(228)103(59-115(208)209)183-145(237)109(68-198)189-149(241)121(77(10)201)194-140(232)100(53-79-26-16-13-17-27-79)185-148(240)120(76(9)200)191-114(207)64-166-125(217)92(41-43-111(154)204)172-142(234)106(65-195)186-124(216)87(153)57-83-63-162-70-167-83/h12-19,24-29,33-40,62-63,70-77,87,89-110,118-121,165,195-203,242H,20-23,30-32,41-61,64-69,152-153H2,1-11H3,(H2,154,204)(H2,155,205)(H2,156,206)(H2,157,214)(H,162,167)(H,166,217)(H,168,218)(H,169,219)(H,170,235)(H,171,236)(H,172,234)(H,173,223)(H,174,239)(H,175,225)(H,176,227)(H,177,220)(H,178,228)(H,179,229)(H,180,221)(H,181,222)(H,182,224)(H,183,237)(H,184,238)(H,185,240)(H,186,216)(H,187,226)(H,188,230)(H,189,241)(H,190,215)(H,191,207)(H,192,231)(H,193,233)(H,194,232)(H,208,209)(H,210,211)(H,212,213)(H4,158,159,163)(H4,160,161,164)/t74-,75+,76+,77+,87-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,118-,119-,120-,121-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277080
(CHEMBL4172444)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H219N41O48S2/c1-70(2)49-94(131(221)170-93(45-48-241-11)130(220)178-101(57-113(156)204)141(231)190-119(74(8)196)122(157)212)173-135(225)100(55-81-61-162-87-28-19-18-27-85(81)87)177-129(219)92(41-44-112(155)203)171-147(237)118(72(5)6)189-139(229)98(51-77-23-14-12-15-24-77)176-136(226)102(58-115(206)207)179-128(218)91(40-43-111(154)202)166-123(213)73(7)165-146(236)109(68-240)187-127(217)89(30-22-47-161-150(158)159)168-144(234)107(66-194)185-138(228)104(60-117(210)211)180-132(222)95(50-71(3)4)172-133(223)96(53-79-31-35-83(199)36-32-79)174-126(216)88(29-20-21-46-151)167-143(233)106(65-193)184-134(224)97(54-80-33-37-84(200)38-34-80)175-137(227)103(59-116(208)209)181-145(235)108(67-195)186-149(239)121(76(10)198)191-140(230)99(52-78-25-16-13-17-26-78)182-148(238)120(75(9)197)188-114(205)63-163-125(215)90(39-42-110(153)201)169-142(232)105(64-192)183-124(214)86(152)56-82-62-160-69-164-82/h12-19,23-28,31-38,61-62,69-76,86,88-109,118-121,162,192-200,240H,20-22,29-30,39-60,63-68,151-152H2,1-11H3,(H2,153,201)(H2,154,202)(H2,155,203)(H2,156,204)(H2,157,212)(H,160,164)(H,163,215)(H,165,236)(H,166,213)(H,167,233)(H,168,234)(H,169,232)(H,170,221)(H,171,237)(H,172,223)(H,173,225)(H,174,216)(H,175,227)(H,176,226)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,235)(H,182,238)(H,183,214)(H,184,224)(H,185,228)(H,186,239)(H,187,217)(H,188,205)(H,189,229)(H,190,231)(H,191,230)(H,206,207)(H,208,209)(H,210,211)(H4,158,159,161)/t73-,74+,75+,76+,86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,118-,119-,120-,121-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277068
(CHEMBL4167169)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H219N41O48S2/c1-70(2)49-94(131(221)170-93(45-48-241-11)130(220)178-101(57-113(156)204)141(231)190-119(74(8)196)122(157)212)173-135(225)100(55-81-61-162-87-28-19-18-27-85(81)87)177-129(219)92(41-44-112(155)203)171-147(237)118(72(5)6)189-139(229)98(51-77-23-14-12-15-24-77)176-136(226)102(58-115(206)207)179-128(218)91(40-43-111(154)202)166-123(213)73(7)165-126(216)89(30-22-47-161-150(158)159)168-146(236)109(68-240)187-145(235)107(66-194)185-138(228)104(60-117(210)211)180-132(222)95(50-71(3)4)172-133(223)96(53-79-31-35-83(199)36-32-79)174-127(217)88(29-20-21-46-151)167-143(233)106(65-193)184-134(224)97(54-80-33-37-84(200)38-34-80)175-137(227)103(59-116(208)209)181-144(234)108(67-195)186-149(239)121(76(10)198)191-140(230)99(52-78-25-16-13-17-26-78)182-148(238)120(75(9)197)188-114(205)63-163-125(215)90(39-42-110(153)201)169-142(232)105(64-192)183-124(214)86(152)56-82-62-160-69-164-82/h12-19,23-28,31-38,61-62,69-76,86,88-109,118-121,162,192-200,240H,20-22,29-30,39-60,63-68,151-152H2,1-11H3,(H2,153,201)(H2,154,202)(H2,155,203)(H2,156,204)(H2,157,212)(H,160,164)(H,163,215)(H,165,216)(H,166,213)(H,167,233)(H,168,236)(H,169,232)(H,170,221)(H,171,237)(H,172,223)(H,173,225)(H,174,217)(H,175,227)(H,176,226)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,234)(H,182,238)(H,183,214)(H,184,224)(H,185,228)(H,186,239)(H,187,235)(H,188,205)(H,189,229)(H,190,231)(H,191,230)(H,206,207)(H,208,209)(H,210,211)(H4,158,159,161)/t73-,74+,75+,76+,86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,118-,119-,120-,121-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277056
(CHEMBL4163714)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C152H226N44O46S2/c1-72(2)52-97(133(225)176-96(47-51-244-11)132(224)184-104(60-115(158)209)142(234)195-120(76(8)201)123(159)215)179-137(229)103(58-83-63-167-89-29-19-18-28-87(83)89)183-131(223)95(43-46-114(157)208)177-148(240)119(74(5)6)194-140(232)101(54-79-24-14-12-15-25-79)182-138(230)105(61-117(211)212)185-130(222)94(42-45-113(156)207)171-124(216)75(7)170-127(219)91(31-22-49-165-151(160)161)172-128(220)92(32-23-50-166-152(162)163)174-145(237)109(68-199)190-147(239)111(70-243)192-134(226)98(53-73(3)4)178-135(227)99(56-81-33-37-85(204)38-34-81)180-129(221)90(30-20-21-48-153)173-144(236)108(67-198)189-136(228)100(57-82-35-39-86(205)40-36-82)181-139(231)106(62-118(213)214)186-146(238)110(69-200)191-150(242)122(78(10)203)196-141(233)102(55-80-26-16-13-17-27-80)187-149(241)121(77(9)202)193-116(210)65-168-126(218)93(41-44-112(155)206)175-143(235)107(66-197)188-125(217)88(154)59-84-64-164-71-169-84/h12-19,24-29,33-40,63-64,71-78,88,90-111,119-122,167,197-205,243H,20-23,30-32,41-62,65-70,153-154H2,1-11H3,(H2,155,206)(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,215)(H,164,169)(H,168,218)(H,170,219)(H,171,216)(H,172,220)(H,173,236)(H,174,237)(H,175,235)(H,176,225)(H,177,240)(H,178,227)(H,179,229)(H,180,221)(H,181,231)(H,182,230)(H,183,223)(H,184,224)(H,185,222)(H,186,238)(H,187,241)(H,188,217)(H,189,228)(H,190,239)(H,191,242)(H,192,226)(H,193,210)(H,194,232)(H,195,234)(H,196,233)(H,211,212)(H,213,214)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,119-,120-,121-,122-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277084
(CHEMBL4160347)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C147H222N44O47S2/c1-68(2)48-91(128(221)171-90(43-47-240-11)127(220)178-97(55-109(153)203)137(230)190-115(72(8)196)118(154)211)173-131(224)96(53-78-59-162-83-29-19-18-28-81(78)83)177-126(219)89(39-42-108(152)202)172-143(236)114(70(5)6)189-135(228)94(50-75-24-14-12-15-25-75)176-132(225)98(56-111(205)206)179-125(218)88(38-41-107(151)201)166-119(212)71(7)165-122(215)85(31-22-45-160-146(155)156)167-123(216)86(32-23-46-161-147(157)158)169-140(233)103(64-194)185-134(227)100(58-113(209)210)180-129(222)92(49-69(3)4)174-142(235)105(66-239)187-124(217)84(30-20-21-44-148)168-139(232)102(63-193)184-130(223)93(52-77-33-35-80(199)36-34-77)175-133(226)99(57-112(207)208)181-141(234)104(65-195)186-145(238)117(74(10)198)191-136(229)95(51-76-26-16-13-17-27-76)182-144(237)116(73(9)197)188-110(204)61-163-121(214)87(37-40-106(150)200)170-138(231)101(62-192)183-120(213)82(149)54-79-60-159-67-164-79/h12-19,24-29,33-36,59-60,67-74,82,84-105,114-117,162,192-199,239H,20-23,30-32,37-58,61-66,148-149H2,1-11H3,(H2,150,200)(H2,151,201)(H2,152,202)(H2,153,203)(H2,154,211)(H,159,164)(H,163,214)(H,165,215)(H,166,212)(H,167,216)(H,168,232)(H,169,233)(H,170,231)(H,171,221)(H,172,236)(H,173,224)(H,174,235)(H,175,226)(H,176,225)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,234)(H,182,237)(H,183,213)(H,184,223)(H,185,227)(H,186,238)(H,187,217)(H,188,204)(H,189,228)(H,190,230)(H,191,229)(H,205,206)(H,207,208)(H,209,210)(H4,155,156,160)(H4,157,158,161)/t71-,72+,73+,74+,82-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,114-,115-,116-,117-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50266668
(CHEMBL4098545)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](C)C(O)=O |r| Show InChI InChI=1S/C192H295N61O60S/c1-15-92(8)149(184(308)220-94(10)188(312)313)251-177(301)128(76-142(201)268)240-171(295)127(75-141(200)267)238-161(285)114(43-31-64-215-192(209)210)224-170(294)126(74-140(199)266)237-160(284)113(42-30-63-214-191(207)208)223-157(281)110(39-25-27-60-194)229-186(310)151(96(12)259)253-178(302)129(77-143(202)269)239-164(288)118(58-65-314-14)228-165(289)119(66-89(2)3)232-169(293)125(72-102-81-216-108-37-23-22-36-106(102)108)236-163(287)117(54-57-139(198)265)230-183(307)148(91(6)7)250-175(299)123(68-98-32-18-16-19-33-98)235-172(296)130(78-145(271)272)241-162(286)116(53-56-138(197)264)221-153(277)93(9)219-156(280)111(40-28-61-212-189(203)204)222-158(282)112(41-29-62-213-190(205)206)226-181(305)135(86-256)247-174(298)132(80-147(275)276)242-166(290)120(67-90(4)5)231-167(291)121(70-100-44-48-104(261)49-45-100)233-159(283)109(38-24-26-59-193)225-180(304)134(85-255)246-168(292)122(71-101-46-50-105(262)51-47-101)234-173(297)131(79-146(273)274)243-182(306)136(87-257)248-187(311)152(97(13)260)252-176(300)124(69-99-34-20-17-21-35-99)244-185(309)150(95(11)258)249-144(270)83-217-155(279)115(52-55-137(196)263)227-179(303)133(84-254)245-154(278)107(195)73-103-82-211-88-218-103/h16-23,32-37,44-51,81-82,88-97,107,109-136,148-152,216,254-262H,15,24-31,38-43,52-80,83-87,193-195H2,1-14H3,(H2,196,263)(H2,197,264)(H2,198,265)(H2,199,266)(H2,200,267)(H2,201,268)(H2,202,269)(H,211,218)(H,217,279)(H,219,280)(H,220,308)(H,221,277)(H,222,282)(H,223,281)(H,224,294)(H,225,304)(H,226,305)(H,227,303)(H,228,289)(H,229,310)(H,230,307)(H,231,291)(H,232,293)(H,233,283)(H,234,297)(H,235,296)(H,236,287)(H,237,284)(H,238,285)(H,239,288)(H,240,295)(H,241,286)(H,242,290)(H,243,306)(H,244,309)(H,245,278)(H,246,292)(H,247,298)(H,248,311)(H,249,270)(H,250,299)(H,251,301)(H,252,300)(H,253,302)(H,271,272)(H,273,274)(H,275,276)(H,312,313)(H4,203,204,212)(H4,205,206,213)(H4,207,208,214)(H4,209,210,215)/t92-,93-,94-,95+,96+,97+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,148-,149-,150-,151-,152-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 12 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50266693
(CHEBI:5391 | Glucagen Hypokit | Glucagon | Glucago...)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O Show InChI InChI=1S/C153H225N43O49S/c1-72(2)52-97(133(226)176-96(47-51-246-11)132(225)184-104(60-115(159)209)143(236)196-123(78(10)203)151(244)245)179-137(230)103(58-83-64-167-89-29-19-18-28-87(83)89)183-131(224)95(43-46-114(158)208)177-148(241)120(74(5)6)194-141(234)101(54-79-24-14-12-15-25-79)182-138(231)105(61-117(211)212)185-130(223)94(42-45-113(157)207)171-124(217)75(7)170-127(220)91(31-22-49-165-152(160)161)172-128(221)92(32-23-50-166-153(162)163)174-146(239)110(69-199)191-140(233)107(63-119(215)216)186-134(227)98(53-73(3)4)178-135(228)99(56-81-33-37-85(204)38-34-81)180-129(222)90(30-20-21-48-154)173-145(238)109(68-198)190-136(229)100(57-82-35-39-86(205)40-36-82)181-139(232)106(62-118(213)214)187-147(240)111(70-200)192-150(243)122(77(9)202)195-142(235)102(55-80-26-16-13-17-27-80)188-149(242)121(76(8)201)193-116(210)66-168-126(219)93(41-44-112(156)206)175-144(237)108(67-197)189-125(218)88(155)59-84-65-164-71-169-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,167,197-205H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H,164,169)(H,168,219)(H,170,220)(H,171,217)(H,172,221)(H,173,238)(H,174,239)(H,175,237)(H,176,226)(H,177,241)(H,178,228)(H,179,230)(H,180,222)(H,181,232)(H,182,231)(H,183,224)(H,184,225)(H,185,223)(H,186,227)(H,187,240)(H,188,242)(H,189,218)(H,190,229)(H,191,233)(H,192,243)(H,193,210)(H,194,234)(H,195,235)(H,196,236)(H,211,212)(H,213,214)(H,215,216)(H,244,245)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 7.70 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50121518
(CHEMBL428139)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O |wU:119.121,95.99,89.93,105.111,142.150,8.16,195.200,134.137,69.74,28.34,210.215,223.228,156.159,164.169,167.172,42.43,176.180,2.2,wD:113.117,123.133,101.103,203.208,4.4,181.184,77.87,19.25,47.53,60.66,37.38,151.154,(42.46,-37.33,;42.37,-38.87,;40.99,-39.57,;39.7,-38.74,;40.89,-41.1,;42.2,-41.97,;43.56,-41.27,;43.68,-39.74,;44.87,-42.13,;44.77,-43.67,;43.39,-44.36,;42.09,-43.51,;40.71,-44.19,;40.63,-45.74,;41.92,-46.56,;43.3,-45.88,;46.26,-41.41,;48.15,-38.22,;50.19,-38.22,;47.05,-35.91,;45.48,-36.01,;44.58,-34.7,;43,-34.7,;42.23,-33.32,;42.2,-36.08,;47.71,-34.5,;46.82,-33.25,;45.29,-33.35,;47.5,-31.88,;49.02,-31.71,;49.9,-33.02,;51.45,-32.86,;52.3,-34.13,;53.88,-34.01,;46.61,-30.57,;47.28,-29.18,;48.81,-29.04,;46.4,-27.9,;44.85,-28.05,;47.1,-26.52,;46.18,-25.27,;44.66,-25.37,;46.88,-23.89,;48.41,-23.75,;45.97,-22.6,;46.65,-21.19,;48.2,-21.08,;45.79,-19.94,;44.22,-20.08,;43.56,-21.45,;42.02,-21.57,;41.15,-20.3,;41.38,-22.93,;46.44,-18.58,;45.53,-17.27,;44.01,-17.37,;46.23,-15.88,;45.34,-14.62,;46.02,-13.23,;47.54,-13.1,;45.15,-11.97,;43.61,-12.08,;42.91,-13.45,;41.38,-13.59,;40.52,-12.3,;40.73,-14.97,;45.81,-10.56,;44.94,-9.3,;43.4,-9.41,;45.62,-7.92,;47.14,-7.76,;47.99,-9.02,;47.37,-10.45,;49.57,-8.92,;44.71,-6.63,;45.37,-5.25,;46.93,-5.14,;44.5,-3.99,;43,-4.11,;42.31,-5.49,;43.19,-6.74,;42.53,-8.16,;40.99,-8.27,;40.3,-9.63,;40.07,-6.99,;40.77,-5.6,;45.15,-2.58,;44.28,-1.32,;43.19,-2.21,;44.97,.09,;46.51,.19,;47.37,-1.06,;44.05,1.35,;42.74,.58,;42.74,-.96,;41.38,1.35,;41.38,2.88,;42.74,3.65,;40.07,.58,;38.72,1.35,;38.72,2.88,;37.4,.58,;36.05,1.35,;34.73,.58,;34.73,-.96,;33.4,1.35,;33.4,2.88,;34.73,3.65,;36.05,2.88,;34.73,5.21,;32.06,.58,;30.7,1.35,;30.7,2.88,;29.39,.58,;29.39,-.96,;30.7,-1.72,;28.01,1.35,;26.72,.58,;26.72,-.96,;25.34,1.35,;24.03,.58,;22.71,1.35,;22.71,2.88,;21.34,.58,;21.34,-.96,;22.71,-1.72,;24.03,-.96,;25.34,-1.72,;25.34,-3.24,;24.03,-4.06,;22.71,-3.24,;20.04,1.35,;18.69,.58,;18.69,-.96,;17.34,1.35,;16,.58,;14.66,1.35,;14.66,2.88,;13.31,.58,;11.99,1.35,;10.66,.58,;10.66,-.96,;9.3,1.35,;9.3,2.88,;10.66,3.65,;10.66,5.21,;9.3,5.97,;11.99,5.97,;7.98,.58,;6.63,1.35,;6.63,2.88,;5.32,.58,;5.32,-.96,;3.97,1.35,;2.61,.58,;2.61,-.96,;1.3,1.35,;-.02,.58,;1.3,2.88,;2.61,3.65,;4.03,3.04,;5.09,4.18,;4.29,5.54,;2.79,5.21,;17.34,2.88,;16,3.65,;18.69,3.65,;25.34,2.88,;24.03,3.65,;26.72,3.65,;37.4,-.96,;36.05,-1.72,;38.72,-1.72,;39.51,-41.81,;39.42,-43.34,;38.22,-40.98,;36.86,-41.69,;36.79,-43.21,;35.55,-40.81,;35.64,-39.3,;34.19,-41.52,;32.88,-40.66,;32.98,-39.14,;31.68,-38.27,;30.24,-38.81,;29.25,-37.61,;30.14,-36.35,;29.72,-34.87,;30.8,-33.77,;32.32,-34.17,;32.71,-35.65,;31.62,-36.77,;31.52,-41.36,;31.41,-42.91,;30.21,-40.54,;28.83,-41.24,;28.76,-42.74,;27.37,-43.45,;27.31,-44.97,;26.09,-42.6,;27.52,-40.38,;27.62,-38.81,;26.16,-41.08,;24.85,-40.23,;24.97,-38.71,;23.66,-37.83,;26.33,-37.99,;23.49,-40.94,;23.42,-42.46,;22.22,-40.07,;20.82,-40.78,;20.71,-42.3,;19.35,-43.02,;19.28,-44.54,;17.91,-45.25,;17.83,-46.77,;19.51,-39.93,;19.62,-38.38,;18.15,-40.65,;16.87,-39.79,;15.48,-40.49,;15.41,-42.03,;14.17,-39.63,;12.81,-40.33,;12.72,-41.87,;11.36,-42.58,;11.27,-44.1,;9.89,-44.8,;9.8,-46.34,;8.44,-47.05,;11.1,-47.16,;11.5,-39.5,;11.6,-37.94,;10.17,-40.21,;8.86,-39.35,;7.45,-40.07,;6.14,-39.2,;7.38,-41.57,)| Show InChI InChI=1S/C151H228N40O47/c1-17-77(10)121(148(236)169-81(14)127(215)177-105(60-87-63-160-92-36-25-24-35-90(87)92)138(226)179-101(56-74(4)5)139(227)188-119(75(6)7)146(234)176-94(37-26-28-52-152)130(218)161-65-111(199)170-93(39-30-54-159-151(156)157)129(217)164-68-118(210)211)190-140(228)103(57-84-31-20-18-21-32-84)180-135(223)99(47-51-116(206)207)175-134(222)95(38-27-29-53-153)172-125(213)79(12)166-124(212)78(11)168-133(221)98(44-48-110(155)198)171-112(200)66-162-132(220)97(46-50-115(204)205)174-136(224)100(55-73(2)3)178-137(225)102(59-86-40-42-89(197)43-41-86)181-143(231)107(69-192)184-145(233)109(71-194)185-147(235)120(76(8)9)189-142(230)106(62-117(208)209)182-144(232)108(70-193)186-150(238)123(83(16)196)191-141(229)104(58-85-33-22-19-23-34-85)183-149(237)122(82(15)195)187-113(201)67-163-131(219)96(45-49-114(202)203)173-126(214)80(13)167-128(216)91(154)61-88-64-158-72-165-88/h18-25,31-36,40-43,63-64,72-83,91,93-109,119-123,160,192-197H,17,26-30,37-39,44-62,65-71,152-154H2,1-16H3,(H2,155,198)(H,158,165)(H,161,218)(H,162,220)(H,163,219)(H,164,217)(H,166,212)(H,167,216)(H,168,221)(H,169,236)(H,170,199)(H,171,200)(H,172,213)(H,173,214)(H,174,224)(H,175,222)(H,176,234)(H,177,215)(H,178,225)(H,179,226)(H,180,223)(H,181,231)(H,182,232)(H,183,237)(H,184,233)(H,185,235)(H,186,238)(H,187,201)(H,188,227)(H,189,230)(H,190,228)(H,191,229)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H4,156,157,159)/t77-,78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,119-,120-,121-,122-,123-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 0.0700 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277081
(CHEMBL4162383)Show SMILES CCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C160H234N42O50S2/c1-13-14-15-26-53-202-123(217)67-117(159(202)252)254-75-116(155(248)178-96(35-27-52-171-160(168)169)135(228)175-80(8)132(225)176-98(45-48-119(164)213)137(230)189-109(64-124(218)219)145(238)186-105(57-84-28-18-16-19-29-84)148(241)199-127(79(6)7)156(249)181-99(46-49-120(165)214)138(231)187-107(61-88-68-172-94-33-23-22-32-92(88)94)144(237)183-101(55-77(2)3)140(233)180-100(50-54-253-12)139(232)188-108(63-121(166)215)150(243)200-128(81(9)207)131(167)224)197-154(247)114(73-205)195-147(240)111(66-126(222)223)190-141(234)102(56-78(4)5)182-142(235)103(59-86-36-40-90(210)41-37-86)184-136(229)95(34-24-25-51-161)177-152(245)113(72-204)194-143(236)104(60-87-38-42-91(211)43-39-87)185-146(239)110(65-125(220)221)191-153(246)115(74-206)196-158(251)130(83(11)209)201-149(242)106(58-85-30-20-17-21-31-85)192-157(250)129(82(10)208)198-122(216)70-173-134(227)97(44-47-118(163)212)179-151(244)112(71-203)193-133(226)93(162)62-89-69-170-76-174-89/h16-23,28-33,36-43,68-69,76-83,93,95-117,127-130,172,203-211H,13-15,24-27,34-35,44-67,70-75,161-162H2,1-12H3,(H2,163,212)(H2,164,213)(H2,165,214)(H2,166,215)(H2,167,224)(H,170,174)(H,173,227)(H,175,228)(H,176,225)(H,177,245)(H,178,248)(H,179,244)(H,180,233)(H,181,249)(H,182,235)(H,183,237)(H,184,229)(H,185,239)(H,186,238)(H,187,231)(H,188,232)(H,189,230)(H,190,234)(H,191,246)(H,192,250)(H,193,226)(H,194,236)(H,195,240)(H,196,251)(H,197,247)(H,198,216)(H,199,241)(H,200,243)(H,201,242)(H,218,219)(H,220,221)(H,222,223)(H4,168,169,171)/t80-,81+,82+,83+,93-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117?,127-,128-,129-,130-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277060
(CHEMBL4167331)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C152H226N44O46S2/c1-72(2)52-97(133(225)176-96(47-51-244-11)132(224)184-104(60-115(158)209)142(234)195-120(76(8)201)123(159)215)179-137(229)103(58-83-63-167-89-29-19-18-28-87(83)89)183-130(222)95(43-46-114(157)208)177-148(240)119(74(5)6)194-140(232)101(54-79-24-14-12-15-25-79)182-147(239)111(70-243)192-131(223)94(42-45-113(156)207)171-124(216)75(7)170-127(219)91(31-22-49-165-151(160)161)172-128(220)92(32-23-50-166-152(162)163)174-145(237)109(68-199)190-139(231)106(62-118(213)214)185-134(226)98(53-73(3)4)178-135(227)99(56-81-33-37-85(204)38-34-81)180-129(221)90(30-20-21-48-153)173-144(236)108(67-198)189-136(228)100(57-82-35-39-86(205)40-36-82)181-138(230)105(61-117(211)212)186-146(238)110(69-200)191-150(242)122(78(10)203)196-141(233)102(55-80-26-16-13-17-27-80)187-149(241)121(77(9)202)193-116(210)65-168-126(218)93(41-44-112(155)206)175-143(235)107(66-197)188-125(217)88(154)59-84-64-164-71-169-84/h12-19,24-29,33-40,63-64,71-78,88,90-111,119-122,167,197-205,243H,20-23,30-32,41-62,65-70,153-154H2,1-11H3,(H2,155,206)(H2,156,207)(H2,157,208)(H2,158,209)(H2,159,215)(H,164,169)(H,168,218)(H,170,219)(H,171,216)(H,172,220)(H,173,236)(H,174,237)(H,175,235)(H,176,225)(H,177,240)(H,178,227)(H,179,229)(H,180,221)(H,181,230)(H,182,239)(H,183,222)(H,184,224)(H,185,226)(H,186,238)(H,187,241)(H,188,217)(H,189,228)(H,190,231)(H,191,242)(H,192,223)(H,193,210)(H,194,232)(H,195,234)(H,196,233)(H,211,212)(H,213,214)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,119-,120-,121-,122-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277053
(CHEMBL4174382)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C150H220N44O48S2/c1-70(2)50-94(131(225)174-93(45-49-244-9)130(224)181-100(57-112(156)207)140(234)193-118(73(6)199)121(157)215)176-134(228)99(55-80-61-165-86-27-17-16-26-84(80)86)180-129(223)92(41-44-111(155)206)175-146(240)117(71(3)4)192-138(232)97(51-76-22-12-10-13-23-76)179-135(229)101(58-114(209)210)182-128(222)91(40-43-110(154)205)169-122(216)72(5)168-125(219)88(29-20-47-163-149(158)159)170-126(220)89(30-21-48-164-150(160)161)172-143(237)106(66-197)188-137(231)103(60-116(213)214)184-145(239)108(68-243)190-133(227)96(54-79-33-37-83(203)38-34-79)177-127(221)87(28-18-19-46-151)171-142(236)105(65-196)187-132(226)95(53-78-31-35-82(202)36-32-78)178-136(230)102(59-115(211)212)183-144(238)107(67-198)189-148(242)120(75(8)201)194-139(233)98(52-77-24-14-11-15-25-77)185-147(241)119(74(7)200)191-113(208)63-166-124(218)90(39-42-109(153)204)173-141(235)104(64-195)186-123(217)85(152)56-81-62-162-69-167-81/h10-17,22-27,31-38,61-62,69-75,85,87-108,117-120,165,195-203,243H,18-21,28-30,39-60,63-68,151-152H2,1-9H3,(H2,153,204)(H2,154,205)(H2,155,206)(H2,156,207)(H2,157,215)(H,162,167)(H,166,218)(H,168,219)(H,169,216)(H,170,220)(H,171,236)(H,172,237)(H,173,235)(H,174,225)(H,175,240)(H,176,228)(H,177,221)(H,178,230)(H,179,229)(H,180,223)(H,181,224)(H,182,222)(H,183,238)(H,184,239)(H,185,241)(H,186,217)(H,187,226)(H,188,231)(H,189,242)(H,190,227)(H,191,208)(H,192,232)(H,193,234)(H,194,233)(H,209,210)(H,211,212)(H,213,214)(H4,158,159,163)(H4,160,161,164)/t72-,73+,74+,75+,85-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277072
(CHEMBL4174404)Show SMILES CCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C163H241N45O50S2/c1-12-13-14-25-55-208-125(223)69-119(161(208)258)260-77-118(157(254)185-100(46-49-121(167)219)139(236)195-111(66-126(224)225)147(244)192-107(59-85-28-17-15-18-29-85)150(247)205-129(81(6)7)158(255)187-101(47-50-122(168)220)140(237)193-109(63-89-70-178-95-33-22-21-32-93(89)95)146(243)189-103(57-79(2)3)142(239)186-102(51-56-259-11)141(238)194-110(65-123(169)221)152(249)206-130(82(8)213)133(170)230)203-138(235)98(36-27-54-177-163(173)174)181-136(233)97(35-26-53-176-162(171)172)183-155(252)116(75-211)201-149(246)113(68-128(228)229)196-143(240)104(58-80(4)5)188-144(241)105(61-87-37-41-91(216)42-38-87)190-137(234)96(34-23-24-52-164)182-154(251)115(74-210)200-145(242)106(62-88-39-43-92(217)44-40-88)191-148(245)112(67-127(226)227)197-156(253)117(76-212)202-160(257)132(84(10)215)207-151(248)108(60-86-30-19-16-20-31-86)198-159(256)131(83(9)214)204-124(222)72-179-135(232)99(45-48-120(166)218)184-153(250)114(73-209)199-134(231)94(165)64-90-71-175-78-180-90/h15-22,28-33,37-44,70-71,78-84,94,96-119,129-132,178,209-217H,12-14,23-27,34-36,45-69,72-77,164-165H2,1-11H3,(H2,166,218)(H2,167,219)(H2,168,220)(H2,169,221)(H2,170,230)(H,175,180)(H,179,232)(H,181,233)(H,182,251)(H,183,252)(H,184,250)(H,185,254)(H,186,239)(H,187,255)(H,188,241)(H,189,243)(H,190,234)(H,191,245)(H,192,244)(H,193,237)(H,194,238)(H,195,236)(H,196,240)(H,197,253)(H,198,256)(H,199,231)(H,200,242)(H,201,246)(H,202,257)(H,203,235)(H,204,222)(H,205,247)(H,206,249)(H,207,248)(H,224,225)(H,226,227)(H,228,229)(H4,171,172,176)(H4,173,174,177)/t82-,83-,84-,94+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119?,129+,130+,131+,132+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 9 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277054
(CHEMBL4159275)Show SMILES CCCCCCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C170H254N42O50S2/c1-13-14-15-16-17-18-19-20-21-22-23-24-25-36-63-212-133(227)77-127(169(212)262)264-85-126(165(258)188-106(45-37-62-181-170(178)179)145(238)185-90(8)142(235)186-108(55-58-129(174)223)147(240)199-119(74-134(228)229)155(248)196-115(67-94-38-28-26-29-39-94)158(251)209-137(89(6)7)166(259)191-109(56-59-130(175)224)148(241)197-117(71-98-78-182-104-43-33-32-42-102(98)104)154(247)193-111(65-87(2)3)150(243)190-110(60-64-263-12)149(242)198-118(73-131(176)225)160(253)210-138(91(9)217)141(177)234)207-164(257)124(83-215)205-157(250)121(76-136(232)233)200-151(244)112(66-88(4)5)192-152(245)113(69-96-46-50-100(220)51-47-96)194-146(239)105(44-34-35-61-171)187-162(255)123(82-214)204-153(246)114(70-97-48-52-101(221)53-49-97)195-156(249)120(75-135(230)231)201-163(256)125(84-216)206-168(261)140(93(11)219)211-159(252)116(68-95-40-30-27-31-41-95)202-167(260)139(92(10)218)208-132(226)80-183-144(237)107(54-57-128(173)222)189-161(254)122(81-213)203-143(236)103(172)72-99-79-180-86-184-99/h26-33,38-43,46-53,78-79,86-93,103,105-127,137-140,182,213-221H,13-25,34-37,44-45,54-77,80-85,171-172H2,1-12H3,(H2,173,222)(H2,174,223)(H2,175,224)(H2,176,225)(H2,177,234)(H,180,184)(H,183,237)(H,185,238)(H,186,235)(H,187,255)(H,188,258)(H,189,254)(H,190,243)(H,191,259)(H,192,245)(H,193,247)(H,194,239)(H,195,249)(H,196,248)(H,197,241)(H,198,242)(H,199,240)(H,200,244)(H,201,256)(H,202,260)(H,203,236)(H,204,246)(H,205,250)(H,206,261)(H,207,257)(H,208,226)(H,209,251)(H,210,253)(H,211,252)(H,228,229)(H,230,231)(H,232,233)(H4,178,179,181)/t90-,91+,92+,93+,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127?,137-,138-,139-,140-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 15 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277082
(CHEMBL4159003)Show SMILES CCCCCCCCCCCCCCCCN1C(=O)CC(SC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc2cnc[nH]2)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)C1=O |r| Show InChI InChI=1S/C173H261N45O49S2/c1-13-14-15-16-17-18-19-20-21-22-23-24-25-36-66-218-135(232)80-129(171(218)267)269-87-128(167(263)195-109(47-38-65-187-173(183)184)148(244)193-108(46-37-64-186-172(181)182)147(243)191-92(8)144(240)192-111(57-60-131(177)228)150(246)206-122(77-136(233)234)158(254)203-118(70-96-39-28-26-29-40-96)161(257)215-139(91(6)7)168(264)198-112(58-61-132(178)229)151(247)204-120(74-100-81-188-106-44-33-32-43-104(100)106)157(253)200-114(68-89(2)3)153(249)197-113(62-67-268-12)152(248)205-121(76-133(179)230)163(259)216-140(93(9)222)143(180)239)213-160(256)124(79-138(237)238)207-154(250)115(69-90(4)5)199-155(251)116(72-98-48-52-102(225)53-49-98)201-149(245)107(45-34-35-63-174)194-165(261)126(85-220)211-156(252)117(73-99-50-54-103(226)55-51-99)202-159(255)123(78-137(235)236)208-166(262)127(86-221)212-170(266)142(95(11)224)217-162(258)119(71-97-41-30-27-31-42-97)209-169(265)141(94(10)223)214-134(231)83-189-146(242)110(56-59-130(176)227)196-164(260)125(84-219)210-145(241)105(175)75-101-82-185-88-190-101/h26-33,39-44,48-55,81-82,88-95,105,107-129,139-142,188,219-226H,13-25,34-38,45-47,56-80,83-87,174-175H2,1-12H3,(H2,176,227)(H2,177,228)(H2,178,229)(H2,179,230)(H2,180,239)(H,185,190)(H,189,242)(H,191,243)(H,192,240)(H,193,244)(H,194,261)(H,195,263)(H,196,260)(H,197,249)(H,198,264)(H,199,251)(H,200,253)(H,201,245)(H,202,255)(H,203,254)(H,204,247)(H,205,248)(H,206,246)(H,207,250)(H,208,262)(H,209,265)(H,210,241)(H,211,252)(H,212,266)(H,213,256)(H,214,231)(H,215,257)(H,216,259)(H,217,258)(H,233,234)(H,235,236)(H,237,238)(H4,181,182,186)(H4,183,184,187)/t92-,93+,94+,95+,105-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129?,139-,140-,141-,142-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277083
(CHEMBL4159426)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C151H223N43O47S2/c1-71(2)50-95(131(223)173-94(45-49-243-11)130(222)181-102(58-113(156)206)141(233)193-119(75(8)199)122(157)214)176-135(227)101(56-82-62-165-88-29-19-18-28-86(82)88)180-129(221)93(42-44-112(155)205)174-147(239)118(73(5)6)192-139(231)99(52-78-24-14-12-15-25-78)179-137(229)104(60-116(210)211)184-146(238)110(69-242)190-123(215)74(7)168-126(218)90(31-22-47-163-150(158)159)169-127(219)91(32-23-48-164-151(160)161)171-144(236)108(67-197)188-138(230)105(61-117(212)213)182-132(224)96(51-72(3)4)175-133(225)97(54-80-33-37-84(202)38-34-80)177-128(220)89(30-20-21-46-152)170-143(235)107(66-196)187-134(226)98(55-81-35-39-85(203)40-36-81)178-136(228)103(59-115(208)209)183-145(237)109(68-198)189-149(241)121(77(10)201)194-140(232)100(53-79-26-16-13-17-27-79)185-148(240)120(76(9)200)191-114(207)64-166-125(217)92(41-43-111(154)204)172-142(234)106(65-195)186-124(216)87(153)57-83-63-162-70-167-83/h12-19,24-29,33-40,62-63,70-77,87,89-110,118-121,165,195-203,242H,20-23,30-32,41-61,64-69,152-153H2,1-11H3,(H2,154,204)(H2,155,205)(H2,156,206)(H2,157,214)(H,162,167)(H,166,217)(H,168,218)(H,169,219)(H,170,235)(H,171,236)(H,172,234)(H,173,223)(H,174,239)(H,175,225)(H,176,227)(H,177,220)(H,178,228)(H,179,229)(H,180,221)(H,181,222)(H,182,224)(H,183,237)(H,184,238)(H,185,240)(H,186,216)(H,187,226)(H,188,230)(H,189,241)(H,190,215)(H,191,207)(H,192,231)(H,193,233)(H,194,232)(H,208,209)(H,210,211)(H,212,213)(H4,158,159,163)(H4,160,161,164)/t74-,75+,76+,77+,87-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,118-,119-,120-,121-/m0/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description
Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046
BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this
Ligand-Target Pair | |
Search and Browse
